Abstracts Presented at Meetings July 1, 2001 – June 30, 2004 Abu-Orf, M., J. Brewster, J.A. Oleszkiewicz, K.M. Coombs, R.S. Reimers, P. Lagasse, B. Amy, and D. Glindmann. (2003). Production of class A biosolids with anoxic low dose alkaline treatment and odor management. Aidara-Kane A., S.M. DeLong, T.M. Chiller, J.A. Wagenaar, H.C. Wegener, L.-K. Ng, M. Jouan, F.J. Angulo and WHO Global Salm-Surv. World Health Organization Global Salm-Surv: working to reduce foodborne disease globally. ICEID meeting, Georgia, Atlanta, February 28-March 5, 2004. Alfa MJ, DeGagne P, Nagy R, Harding GKM. Correlation of PFGE profile and antibiotic susceptibility profile for MRSA strains. Presented at the 2003 Conjoint Meeting of CACMID and AMQ. Montreal, Quebec. November 2 – 5, 2003. Alfa MJ. Routine Cleaning Methods for Reprocessing of Triple-lumen Sphinctertomes that are SUDs may leave patient-material in the wire channel. Presented at the CACMID 2001 Conference in Victoria, B.C., Nov. 4 - 8, 2001. Alfa, M, Hoban S, Nagy R, Harding GKM. Ward screening for MRSA: Optimization of sample collection. Presented at the 2003 Conjoint Meeting of CACMID and AMQ. Montreal, Quebec. November 2 – 5, 2003. Alimonti JB, Kimani J and Fowke KR. Determination of CD4+ T Lymphocyte HIV-1 p24 Epitope Specificity in HIV Resistance. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada. Alimonti JB, Kimani J, Matu L, Mwenga C, Plummer FA and Fowke KR. HIV-1 Resistant Commercial Sex Workers have a HIV-specific CD4+ T cell Response. Molecular Mechanisms of HIV Pathogenesis Keystone Symposia, April 12-18, 2004 Whistler, B.C. Allen J, Clark CG, Woodward DL, Tabor HA, Foster R, Rodgers FG. Extension of the PCR-RFLP method for determining O-serogroups of Escherichia coli. American Society for Microbiology Annual General Meeting, Salt Lake City, Utah, May 2002 Amiali, M.N., Mulvey, M.R., Berger-Bachi, B., Louie, L., Ismail, A.A., Somorjai, R.L., Simor, A.E. evaluation of fourier transform infrared (FTIR) spectroscopy for the accurate identification of coagulase-negative Staphylococci (CNS) and methicillin-resistant CNS (MRCNS). 42 rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA, Sept. 14-17, 2002.
Transcript
Abstracts Presented at Meetings July 1, 2001 – June 30, 2004
Abu-Orf, M., J. Brewster, J.A. Oleszkiewicz, K.M. Coombs, R.S. Reimers, P. Lagasse, B. Amy, and D. Glindmann. (2003). Production of class A biosolids with anoxic low dose alkaline treatment and odor management.
Aidara-Kane A., S.M. DeLong, T.M. Chiller, J.A. Wagenaar, H.C. Wegener, L.-K. Ng, M. Jouan, F.J. Angulo and WHO Global Salm-Surv. World Health Organization Global Salm-Surv: working to reduce foodborne disease globally. ICEID meeting, Georgia, Atlanta, February 28-March 5, 2004.Alfa MJ, DeGagne P, Nagy R, Harding GKM. Correlation of PFGE profile and antibiotic susceptibility profile for MRSA strains. Presented at the 2003 Conjoint Meeting of CACMID and AMQ. Montreal, Quebec. November 2 – 5, 2003.Alfa MJ. Routine Cleaning Methods for Reprocessing of Triple-lumen Sphinctertomes that are SUDs may leave patient-material in the wire channel. Presented at the CACMID 2001 Conference in Victoria, B.C., Nov. 4 - 8, 2001.Alfa, M, Hoban S, Nagy R, Harding GKM. Ward screening for MRSA: Optimization of sample collection. Presented at the 2003 Conjoint Meeting of CACMID and AMQ. Montreal, Quebec. November 2 – 5, 2003.Alimonti JB, Kimani J and Fowke KR. Determination of CD4+ T Lymphocyte HIV-1 p24 Epitope Specificity in HIV Resistance. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada.Alimonti JB, Kimani J, Matu L, Mwenga C, Plummer FA and Fowke KR. HIV-1 Resistant Commercial Sex Workers have a HIV-specific CD4+ T cell Response. Molecular Mechanisms of HIV Pathogenesis Keystone Symposia, April 12-18, 2004 Whistler, B.C.Allen J, Clark CG, Woodward DL, Tabor HA, Foster R, Rodgers FG. Extension of the PCR-RFLP method for determining O-serogroups of Escherichia coli. American Society for Microbiology Annual General Meeting, Salt Lake City, Utah, May 2002Amiali, M.N., Mulvey, M.R., Berger-Bachi, B., Louie, L., Ismail, A.A., Somorjai, R.L., Simor, A.E. evaluation of fourier transform infrared (FTIR) spectroscopy for the accurate identification of coagulase-negative Staphylococci (CNS) and methicillin-resistant CNS (MRCNS). 42rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA, Sept. 14-17, 2002.
Amiali, M.N., Mulvey, MR, Ismail, A.A. Somorjai, R.L., Simor, A.E. Evaluation of Fourier Transform Infrared (FTIR) Spectroscopy for Epidemiological Typing of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Dec. 15-19, 2001.Andonov A., M. Morbey and J. Rochefort. Performance characteristics of INNO-LIA HCV III Update Assay for confirmation of HCV antibodies. 2003; 72nd Annual CACMID (Canadian Association for Clinical Microbiology and Infectious Diseases) Meeting, November 2-5, 2003, Montreal. Ao Z-j, N. Rougeau, E.A. Cohen, and X-J Yao. Generation and characterization of an HIV-1 single-cycle replication system, a potential vaccine for the control of HIV-1/AIDS. Second Annual Scientific Meeting of Canadian Vaccine Networks (CANVAC), Sainte Adele, Quebec, March 8 to 11, 2002.Ao Z-j, X-J Yao and E.A. Cohen. Assessment of the role of the central DNA flap in HIV-1 single-cycle infection systems. Retroviruses Meeting, Cold Spring Harbor. New York. May 20 - 25, 2003. Ao Z-j, X-J Yao and E.A. Cohen. Assessment of the role of the central DNA flap in HIV-1 replication using single-cycle infection systems. CAHR 2004: Translation of Science into Health. 13th Annual Canadian Conference on HIV/AIDS Research. Montreal, Quebec. May 13-16, 2004.Aoki FY, Macleod MD, Paggiaro P, Wat C, Waalberg E, Ward P on behalf of the IMPACT Study Group. Early administration of oral oseltamivir maximizes the benefits of influenza treatment. International Congress of Chemotherapy, June 30-July 3, 2001, Amsterdam.Aoki FY, Peterson S, Black C. Pharmacoepidemiology of Herpes zoster treatment with antiviral drugs in Manitoba: a population-based study, 1996-2001. 25th Anniversary Meeting of the Canadian Society for Clinical Pharmacology, September 19-21, 2003, Ottawa.Ariano R, Nylan A, Donnelly J, Harding G, Zelenitsky S, Sitar D. Population pharmacokinetics of meropenem in febrile neutropenics using NPEM and optimal sampling design. Presented at the American Society of Clinical Pharmacology and Therapeutics. Washington, DC. March 2003.Ariano RE, Franczuk C, Fine A, Harding GKM, Zelenitsky SA. Peritoneal Dialysis-Related Staphylococcus epidermidis Peritonitis: the Effect of Methicillin Resistance on Clinical Outcome. Presented at the 41st ICAAC. Chicago, IL. September 22-25, 2001.Ariano, RE, Nyhlen A, Donnelly JP, Sitar DS, Harding GKM, Zelenitsky SA. The Pharmacodynamics (PD) of Meropenem in Febrile Neutropenic with Bacteremia. Presented at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL. September 14 – 17, 2003.Artsob H, Drebot M, Dibernardo A, Ogden J, Baikie M, Maloney R, Goltz J, Whitney H, Lindsay R. 2003. Ixodes scapularis and its associated pathogens in Atlantic Canada. American Society of Tropical Medicine and Hygiene 52nd Annual Meeting, December 3-7, Philadelphia, Pennsylvania.Artsob H, Kuno G, Karabatsos N, Tsuchiya KR, Chang JJ, Drebot MA. (2001) Phylogenetic studies on Powassan and deer tick virus isolates. 2001 International Northwest Conference on Diseases in Nature Communicable to Man, 56th Annual Meeting, July 29-August 1, Winnipeg, Manitoba.
Artsob H, Kuno G, Karabatsos N, Tsuchiya KR, Chang JJ, Fearon M, Drebot MA. (2001). Powassan virus: phylogenetic studies from a Canadian perspective. 2001 Conjoint Meeting, Canadian Association of Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.Artsob H, Lindsay R, Buck P, Sockett P, Drebot M. 2004. Arbovirus activity in Canada. 2nd International Congress on Dengue and Yellow Fever. May 31-June 3, Havana, Cuba.Artsob H, Lindsay R, Dibernardo A, Dick D, Holloway K, Drebot M. 2001. Hantavirus activity in Canada: an overview. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Artsob H, Lindsay R, Dibernardo A, Dick D, Holloway K, Shead S, Drebot,M. 2003. Hantavirus activity in Canada: 1989-2002. Annual Meeting of the Southwest Conference on Diseases in Nature Transmissible to Man, June 25-27, Amarillo, Texas. Artsob H, MacPherson D, Feldmann H. 2001. Viral hemorrhagic fever scare in Hamilton, Ontario, February, 2001. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Artsob H. 2002. Introductory comments as Chairperson of Symposium entitled Update on Emerging Infectious Diseases, Canadian Association for Clinical Microbiology and Infectious Diseases, November 3-6, Halifax, Nova Scotia.Artsob H. 2002. President’s welcoming remarks. 57th International Conference on Diseases in Nature Communicable to Man, August 10-13, Vancouver, British Columbia.Artsob H. 2003. Considerations for managing West Nile virus: 2003 and beyond. National West Nile Review and Planning Meeting, January 7-8, Ottawa, Ontario.Bailey RC, Moses S, Agot K, Ndinya-Achola JO. Randomized, controlled trial of male circumcision in Kisumu, Kenya: preliminary baseline results [Abstract 1098727]. XIII International Conference on AIDS and STIs in Africa (ICASA), Nairobi, Kenya, September 21-26, 2003Bailey RC, Okamo PL, Oroko EM, Ndinya-Achola JO, Moses S. The feasibility of a randomized controlled trail of male circumcision to reduce HIV incidence in Kisumu, Kenya [Abstract ThPeC7407]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002Ball TB, Kimani J, Embree JE, Bwayo JJ, Plummer FA, Hayglass KT. Systemic levels of type-1 (IP-10 and MIG), and type-2 (TARG, MDC and EOTAXIN) chemokines in HIV-1 highly exposed, persistently seronegative (HEPS) and HIV infected sex workers from Nairobi, Kenya. Eleventh Annual Canadian Conference on HIV/AIDS Research (CAHR), Winnipeg, Canada; April 25-28, 2002. (Abstract # 125)Barker I, Lindsay R, Drebot M, Buck P, Artsob H. 2003. West Nile: surveillance and response to an emerging disease in North America. 3rd International Veterinary Vaccines and Diagnostics Conference, July 13-18, Guelph, Ontario.Barker IK, Drebot M, Artsob H, Lindsay LR, Buck P, Meyers R, Leighton F, Templeman R, Dallaire A, Daoust P-Y. 2002. Enhanced passive surveillance for West Nile virus in dead birds in Canada - 2001. 51st Annual Meeting of the Wildlife Disease Association, July 28- August 1, Davis, California.Bastien, N, Ward, D, Van Caeseele, P, Brandt, K, Lee, S, McNabb, G, Klisko, and Li, Y. (2003). Prevalence of human metapneumovirus infection in Canada. XII International Conference on Negative strand viruses. Pisa, Italy.
Bastien, N., Normand, S., Brown, T., Ward, D., Peret,T.C., Boivin, G., Erdman, D.D., and Anderson, L.J., and Li, Y. (2002). Molecular characterization of the N, P, M, and F genes of human metapneumovirus isolated in Canada, XIIth International Congress of Virology, Paris, France.Bastien, N., Ward, D., Hamilton, M., Bowness, D., Norman,s., and Li, Y. (2001). Antigenic and genetic characterization of influenza A H1N1 virus isolates circulating in Canada during the 1999-2000 influenza season. 20th Annual Meeting of the American Society for Virology, Madison, Wisconsin.Bastien. N., Normand. S., Taylor. T., Ward. D., Peret.T.C., Boivin. G., Erdman. D.D. and Anderson. J.J., and Li. Y. (2002). Molecular characterization of human metapneumovirusisolated in Canada. Health Canada Research Forum: From Science to Policy. Ottawa. Baydack, R. ,Jackson, M., Booth, T. Dubois, J., and McKenzie, E. (2002) Infrared microspectroscopic studies of transmissible spongiform encephalopathies in rodents. Pittcon, 17-22 March, New Orleans.Becker M, Orr P, Nicolle L. Metastatic Infection with Fluoroquinolone-Resistant (FR) Streptococcus pneumoniae (Spn) following Levofloxacin (L) Treatment of Fluoroquinolone-Susceptible (FS) Spn. Resident Research Day, Department of Medicine, University of Manitoba, April 13, 2004.
Becker, M. L., A. A. Suchak, R. Zarychanski, J. N. Wolfe, C. Turenne, and A. Kabani,.
Mycobacterium neoaurum Bacteremia in a Hemodialysis Patient. Can. J. Infect. Dis. Canadian Association for Clinical Microbiology and Infectious Diseases, Victoria. November 2001.Bellas J, Wayne S, Ball TB*, Embree JE, and Fowke KR. A polymorphism of the CD4 molecule is associated with increased risk of HIV infection. Canadian Association for HIV Research Annual Meeting April 25-28 2002, Winnipeg, Canada.Belletrutti P, Patry D, Sevick R, Tilley P, Mubareka S, Orr P, Holton D, Houston S, Williams K, McClean K, Conly J. Outbreak of West Nile Virus in the Prairie Provinces in the Summer of 2003: Clinical and Radiographic Features. Canadian Infectious Disease Society Meeting, Alberta, April 30, 2004.Bellyou T, Palatnick L, Rimmer E, Nichol K, Zhanel GG and Hoban DJ. Incidence of penicillin doxycycline macrolide and fluoroquinolone resistant Streptococcus pneumoniae (SPN) in Canada: Results of the Canadian Respiratory Organism Susceptibility Study (CROSS) 1997-2002. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Benes R., C.liu, E. Becker and Gehua Wang*. 2002. Association between Enterohemolysin2 (ehl2) Gene of Escherichia coli with Shiga Toxin Genes (stx). CACMID.Bernard K, Artsob H, Fearon M. 2003. Creating a Canadian network of microbiology laboratories for bioterrorism (BT) response. ASM Biodefence Research Meeting, March 9-12, Baltimore, Maryland.Bernard K, Artsob H, Shuttleworth L, Martin K, Fearon M. 2003. A training program for Tier 1 laboratories for recognition of the bacterial agents of bioterrorism. Canadian Association for Clinical Microbiology and Infectious Diseases, November 2-5, Montreal, Quebec.Bernard K, Fearon M, Artsob H, Heisz M, Tepper M, The Health Canada Working Group. 2001. Response to agents of bioterrorism (BT) by Canadian laboratories: an update from the
Health Canada working group. Canadian Association for Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.Bernard K. and H. Artsob (Health Canada, Winnipeg MB), M. Fearon (Prov Lab, Toronto Ont) for the BT Subcommittee CPHLN. Creating a Canadian Network of Microbiology Laboratories for Bioterrorism (BT) Response. ASM Biodefence Research Conference March 10-13, 2003 Baltimore MD. Bernard K. et al, Health Canada Winnipeg Canada and H. Marchandin, et al. Montpellier, France. Proposal of ‘Dialister microaerophilus’ sp nov, a microaerophilic, Gram negative coccobacillus recovered from human clinical materials in France and Canada. 103rd ASM General Meeting. Washington DC May 2003.Bernard K. et al. The use of the BIOTER data library as adjunct to the characterization of bacterial agents of bioterrorism. 102st ASM General Meeting, May 2002 Salt Lake City, Utah abstract no.C-13Bernard K., L.De Winter and C. Munro. Coryneform taxa recovered from human clinical specimens. May 27 2004. 104th ASM Meeting, New Orleans, LA.Bernard K.1*, H. Artsob, L. Shuttleworth Health Canada (HC) National Microbiology Laboratory (NML) Winnipeg MB, K. Martin, Centres for Emergency Preparedness and Response (CEPR) HC, Ottawa and M. Fearon PHL Toronto Ontario Ministry of Health. A training programme for Tier 1 laboratories for recognition of the bacterial agents of Bioterrorism 71st CACMID meeting, Montreal, Que. Nov. 4 2003.Berry, J.D., Bratic, J., Clavijo, A., P Kitching. (2003) Development of cross-reactive, neutralizing murine mAbs to Foot-and-mouth disease virus. IBC Antibody Engineering, San Diego, Dec. 1-4th.Berry, J.D., Licea, A., Popkov, M., C.F. Barbas, III. (2002) Rapid generation of monoclonal antibodies by in vivo targeting of Dendritic cells. Basic Aspects of Vaccines, 8th Annual National Symposium. Uniformed Services University of the Health Sciences, Bethesda, MD. May 13. Berry, J.D., Rutherford, J., Barbas, III, C.F., and F. Plummer. (2001) IgA+B cells of highly exposed humans as a novel source of therapeutic antibodies. Med. Micro. and Infect. Dis. Retreat.Hecla Island. June 29-July 1. Berry, J.D., Tsang, R., Yuan, X., Lisa Schmidt, Saliba, T., Kabani, A., J. Mogridge. (2004) Development and characterization of monoclonal antibody to recombinant PA toxin of Bacillus anthracis International Conference of Immunology (12th), Montreal, July 18-23. Berry, J.D., Tsang, RT., Jones, S., Sabara, M., Andonov, A., Drebot, M., Nagata, L., Yuan, XY., Nicolas, B, Clavijo, A., Kitching, P., McClarty , D., Plummer, F., Kabani, A. 2003. Monoclonal Antibody Development to agents of Foreign Animal Disease, BioTerrorism Agents, and Emerging Infectious Threats: A centralized approach to Diagnostic and Therapeutic antibody Development. Biodefense 2003, Washington D.C., August 27-28.Bilenki L. and X. Yang. Chlamydia trachomatis infection inhibits the development of airway eosinophilia induced by ragweed. Canadian Society for Immunology annual meeting, April 2001, Banff, AlbertaBilenki L. and X. Yang. IL-10-producing dendritic cells display alterred Toll-like receptor (TLR) expression and contribute to infection-mediated inhibition of RW-driven allergic responses. CIM 27:147A, 2004
Bilenki L. and X. Yang. Inhibition of ragweed induced airway eosinophilic inflammation by chlamydial infection. Keystone Symposia: hygiene, allergy and asthma, Keystone, Colorado, April 2003Bilenki L. and X. Yang. Natural killer T (NKT) cells contribute to airway eosinophilic inflammation in a murine model of asthma-like reaction induced by ragweed. Nov 2002, Quebec city, QuebicBilenki L. and X. Yang. Redirection of ragweed-induced asthma-like reaction by adoptive transfer of dendritic cells from chlamydia-infected mice. World of Allergy, Vancouver, September, Allergy Cin Immunol Int, suppl p143, 2003Bilenki L. and X. Yang. The absence of natural killer T (NKT) cells protects mice from Chlamydia trachomatis mouse pneumonitis infection. British Society for Immunology annual congress meeting, Harrogate, U.K., Dec 2003.Bjornson G, Scheifele D., Halperin S., and members of CPS IMPACT (B. Law). Population-based epidemiology of invasive pneumococcal infection in children in nine urban centres across Canada. 1994-1998. Canadian National Immunization Conference, Victoria, B.C. Dec1-3, 2002. Poster Att Black SR, Lo E, Madariaga MG, Zimmerman M, Segreti J. Nosocomial Pneumonia in the PICU, case control retrospective study on risk factors. Abstract ICAAC, 2002, slide presentation. Manuscript in preparation.Blanchard J, O’Neil J, Washington RG, Ramesh BM, Swarankar R, Moses S. A tale of two states: differentiating between epidemic phase and transmission dynamics in the Indian states of Rajasthan and Karnataka [Abstract 0721]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Blanchard J, Ramesh BM, Orchard TR, Moses S, O’Neil J. Sex work in India: patterns embedded in societal tradition [Abstract 0229]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Bodie-Collins M, MacPherson DW, St John R, Artsob H, Drebot M, Shindman J. 2001. Transplantation donation following yellow fever vaccination. Annual Meeting of the American Society of Tropical Medicine and Hygiene, November 11-15, Atlanta, Georgia.Booth S, Drebot MA. (2001). Application of DNA chip technology for genotyping hantavirus infected deer mice. 2001 Conjoint Meeting, Canadian Association of Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.Booth S, Drebot MA. (2001) Applications of DNA chip technology for genotyping hantavirus infected deer mice. 2001 International Northwest Conference on Diseases in Nature Communicable to Man, 56th Annual Meeting, July 29-August 1, Winnipeg, Manitoba.Booth S.A., C. Bowman, R. Baumgartner, G.C. Sorensen, C. Robertson, R.L. Somorjai. “Mining biomarkers of prion induced neurodegeneration using microarrays”. Ottawa. CHI Lab on a Chip, Zurich (2003).Booth S.A., C. Bowman, R. Baumgartner, G.C. Sorensen, C. Robertson, R.L. Somorjai. “Hunting for markers of prion induced neurodegeneration using microarrays”, Ottawa (2002).Booth S.A., Canadian Association of Clinical Microbiology and Infectious Diseases, Victoria, BC. “Application of DNA Chip Technology for Genotyping Hantavirus Infected Deer Mice”, (2001).
Booth S.A., Canadian Association of Clinical Microbiology and Infectious Diseases, Victoria, BC. “Detection of gyrA and parC Mutations in N.gonorrhoeae Using DNA Array Technology”, (2001).Booth S.A., International Northwest Conference on Diseases in Nature Communicable to Man 56th Annual Meeting, Winnipeg “Applications of DNA chip technology for genotyping hantavirus infected deer mice”, (2001).Booth Stephanie, Garrett Sorensen, Catherine Robertson, Michael Coulthart, Clark Phillipson & Ewan Gibb. “Transcriptional analysis of the mouse central nervous system in response to infection with the scrapie agent”. Iowa. Animal Prion Diseases and the Americas (2004).Booth, T. F. (2001). University of Manitoba Zoology Dept. Seminar, November. Diagnostic Imaging of prion diseases.Booth, T. F. (2001). Presentation: Mad cows, cats and elk: transmissible spongiform encephalopathies. University of Manitoba Health Sciences Centre Bug Day Meeting, 16 October. Booth, T. F. (2001). Presentation: Imaging and detection of spongiform encephalopathies. 30 June: Medical Microbiology Retreat, Elk Island: Booth, T. F. (2003) Invited Seminar "The NML experience with SARS in Canada", 18 July, British Columbia Centre for Disease Control.Booth, T. F. (2003). Laboratory diagnosis. Invited seminar, Current Science of SARS Symposium, National Microbiology Laboratory, 1-2 December, Winnipeg, Manitoba.Booth, T., Baydack, R., Dubois, J. and Jackson, M. (2002) Infra-red spectroscopic detection and magnetic resonance imaging of transmissible spongiform encephalopathy (TSE) infection. Health Canada Research Forum: From Science to Policy. Marriott Hotel, 18-19 November, Ottawa, Ontario.Booth, T., Baydack, R., Dubois, J., Jackson, M. (2002). Diagnosis of transmissible spongiform encephalopathy infection using infra-red spectroscopy and magnetic resonance imaging. Canadian Association for Clinical Microbiology and Infectious Diseases, 70th conjoint meeting on infectious diseases, 3-6 November, Casino Nova Scotia Hotel, Halifax, Nova Scotia.Booth, T.F., Tipples, G., Bastien, N., Li, Y., Jones, S., Feldmann, H., Isaac-Renton, M.J. and Plummer, F. (2004). Laboratory Diagnosis of SARS in Canada: The Predictive Value of Testing. 11th International Congress on Infectious Diseases, 4-7 March, Cancun, Mexico.Boroumandi S., G. Wang, C. Clark and F.G. Rodgers A potential virulence factor with hemolysin activity associated eith the tlyA gene homolog in Campylobacter jejuni. 2001. 51st Annual Meeting of the Canadian Society of Micrologists. Waterloo, ON Canada.Bouchillon S, Johnson B, Hoban D, Johnson J, Stevens T. Comparison in vitro activity of garenoxacin against 618 clinical aerobes and anaerobes isolated from clinical gynecological infections. American Society for Microbiology (ASM), New Orleans, Louisiana, May 2004.Bouchillon S, Johnson B, Hoban D, Johnson J, Stevens T. Piperacillin/tazobactam MIC and disk correlation study for ESBL and non-ESBL producing organisms using NCCLS published guidelines versus proposed breakpoints. American Society for Microbiology (ASM), New Orleans, Louisiana, May 2004.
Boutilier, J. and M.S. Carpenter. Phosphoproteome analysis of a HCV replcion containing cell line. American Society for Virology, McGill University, Montreal, July 10-14, 2004. Abstract P14-8.Bow, E.J., Noskin, G.A., Schwarer, A.P., Laverdière, M., Vesole, D.H. Efficacy of Piperacillin/Tazobactam as Initial Empiric Therapy of Febrile Neutropenia in Patients with Hematologic Malignancy. Blood 2003; 102 (11) Abstract #1000, p. 281a.Bow, E.J., Schwarer, A.P., Laverdière, M., Segal, B.H., Anaissie, E.: Efficacy of Piperacillin/Tazobactam as Initial Empiric Therapy of Febrile Neutropenia in Patients with Haematological Malignancy. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Abstract #3778, Chicago, Illinois, September 14-17, 2003.Boyd D. A., A. B. Olson, M. Silverman, A. McGeer, B. M. Willey, V. Pong-Porter, N. Daneman, and M. R. Mulvey. Identification of a Progenitor of the CTX-M-9 Group of Extended-Spectrum B-Lactamases from Kluyvera spp. Isolated in Guyana. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, D.C., Oct.30-Nov 2nd, 2004. Boyd, D., Van Caeseele, P., Cabral, T., Wylie, J., Giercke, S., Hizon, R., Mulvey, M. Molecular Characterization of the vanE Gene Region from a Vancomycin Resistant Enterococcus faecalis Isolated in Canada. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, British Columbia, Nov. 4-7, 2001.Boyd, D.A, Cloeckaert, A., Chaslus-Dancla, E., Mulvey, M.R. Characterization of Variant Salmonella Genomic Island 1 Multidrug Resistance Regions from Serovars Typhimurium DT104 and Agona. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Dec. 15-19, 2001.Boyle, R.H., Ebel, G., Demarest, V.L., Bennet, C., Bernard, K.A., Kramer, L.D., Fikrig, E., Koski, R.A., Weingartl, H.M., Shi, P.Y., Wong, S.J. (2003) Recombinant West Nile Virus Nonstructural Protein 5 Enables Specific Detection of West Nile Infection in Chickens and Wild Birds. Poster at the INCDNCM, Flagstaff, AZ, August Brandt, K., Li, Y., Chan, E., and Horsman, G. (2002). Monitorining two outbreaks of influenza A (H3N2) and (H1N2) in Saskatchewan, 2001-2002. 70th Conjoint Meeting on Infectious Diseases, Halifax, NS.Bratic, J., Tsang, R., Yuan, W., Clavijo, A., Wright, P., Kitching, P., J.D. Berry. (2004) Development of murine mAbs to Foot-and-mouth disease virus A24: Antigenic, but not biological, cross-reactivity with Asia1. International Veterinary Immunology Symposium, Quebec, July 25-30.Brewster, J., A. Nartey, K.M. Coombs, and J.A. Oleszkiewicz. (2003).Inactivation of reovirus: Impact of lime-pH and temperature in digested and dewatered biosolids. Water Environment Federation, Baltimore, Maryland, Feb. 19-22.Brewster, J., R.S. Reimers, M. Abu-Orf, D. Bowman, P. Lagasse, B. Amy, J.A. Oleszkiewicz, and K.M. Coombs. (2002). Anoxic low-lime and fly ash post-disinfection of anaerobically digested sludge to Class A levels. Water Environment Federation, Chicago, Illinois, Sept. 28 - Oct. 2. British Columbia.Bryden L., C. Bourgeois, D. Johnstone, D. Bader, A. Kabani and M. R. Mulvey. Single Nucleotide Polymorphism Analysis of the pXO1 and pX02 Plasmids of Bacillus anthracis. Canadian Association of Clinical Microbiology and Infectous Diseases (CACMID) 2004 Conjoint Meeting, Nov. 7-10, 2004. Regina, Sask.
Bryden L., D. Johnstone, T. Paziuk, D. Bader, A. Kabani, and M.R. Mulvey. Analysis of Single Nucleotide Polymorphisms in the pX01 Plasmid of Bacillus anthracis ASM Biodefence Research Meeting, March 9-12, 2004. Baltimore MDBryden L., M. Mulvey, Doug Bader, A. Kabani, Eric Leblanc and Michel G. Bergeron. Molecular Epidemiology of Biothreat Agents. CRTI 2004 Summer Symposium June 15-16, Gatineau QCBuck P, Barker I, Drebot M, Lindsay R, Artsob H, Sockett P. 2003. West Nile virus in Canada: what’s all the buzz about? International Conference on Diseases in Nature Communicable to Man, August 2-6, Flagstaff, Arizona.Buck P, Barker I, Drebot M, Lindsay R, Weingartl H, Sockett P, Artsob H. 2001. West Nile virus in Canada? There can no longer be any deNile. Annual Meeting of the American Society of Tropical Medicine and Hygiene, November 11-15, Atlanta, Georgia. Buck P, Barker I, Drebot M, Lindsay R, Weingartl H, Sockett P, Artsob H. 2002. West Nile virus: surveillance activities in Canada. 57th International Conference on Diseases in Nature Communicable to Man, August 10-13, Vancouver, British Columbia.Buck P, Barker I, Drebot M, Lindsay R, Weingartl H, Sockett P, Artsob H. 2002. National surveillance for West Nile virus in Canada. Health Canada Research Forum: From Science to Policy, November 18-19, Ottawa, Ontario.Buck P, Barker I, Drebot M, Lindsay R, Weingartl H, Sockett P, Artsob H, and the West Nile virus National Steering Committee. West Nile virus in Canada? There can no longer be any deNile. (2001). 50th Annual Meeting, American Society of Tropical Medicine and Hygiene, November 11-15, Atlanta, Georgia.Buck P, Barker I, Drebot MA, Lindsay R, Weingartl H, Sockett P, Artsob H, and the West Nile Virus National Steering Committee. (2002). National surveillance for West Nile virus in Canada. Health Canada Research Forum: From Science to Policy. November 18-19, Ottawa, Ontario.Buck P, Barker IK, Drebot M, Lindsay R, Artsob H, Sockett P. 2003. West Nile virus in Canada: surveillance activities for this novel pathogen. Health Canada Research Forum, October 21-22, Ottawa, Ontario.Buck P, Barker IK, Drebot M, Lindsay R, Artsob H, Sockett P. 2003. West Nile virus in Canada: surveillance activities for this recently introduced and emerging pathogen. American Society of Tropical Medicine and Hygiene 52nd Annual Meeting, December 3-7, Philadelphia, Pennsylvania..Buck P, Sockett P, Barker I, Lindsay R, Drebot M, Artsob H and the West Nile Virus National Steering Committee.2001. West Nile virus: surveillance activities in Canada. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Buck PA, Sockett P, Barker IK, Drebot M, Lindsay R, Artsob H, Weingartl H. 2002. West Nile: surveillance activities in Canada. International Conference on Zoonoses: From Science to Policy, October 21-23, Cardiff, Wales. Buck PA, Sockett P, Barker IK, Drebot M, Lindsay R, Artsob HJ (2003) West Nile virus: surveillance activities in Canada. Ann Epidemiol. 13:582. Buck, P., Barker, I., Drebot, M., Lindsay, R., Weingartl, H., Sockett, P., Artsob, H., and the West Nile virus National Steering Committee. (2002) National Surveillance for West Nile virus
in Canada. Poster and presentation: Health Canada Research Forum: From Science to Policy, Ottawa, November 18 - 19. Buck, P., Barker, I., Drebot, M., Lindsay, R., Weingartl, H., Sockett, P., Artsob, H., and the West Nile virus National Steering committee (2002) West Nile virus: Surveillance activities in Canada. INCDNCM, Vancouver, BC, August 10 - 13.Buck, P., Barker, I., Drebot, M., Lindsay, R., Weingartl, H., Sockett, P., Artsob, H. and the West Nile virus National Steering Committee:”West Nile virus in Canada? There can no longer be any deNile.”, poster at the meeting of American Society of Tropical Medicine and Hygiene, Atlanta, Nov.11-15, 2001Burbidge E, Artsob H, Drebot M. 2001. Genetic characterization of Canadian snowshoe hare virus isolates. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Burgener, A., K. Coombs, and M. Butler. (2003). The significance of intracellular [ATP] to reovirus production. 6th Annual Protein Expression in Animal Cells Conference, Mont Tremblant, Quebec, Canada, Sept. 7-11.Campbell JL, J. D. Spreitzer, M.R. Mulvey, and Canadian Hospital and Provincial Health Laboratories. Pulsed-Field Gel Electrophoresis Typing of Methicillin-Resistant Staphylococcus aureus in Canada: An Exercise in the Standardization of Methods and Nomenclature. Canadian Association for Clinical Microbiology and Infectious Diseases 72nd Conjoint Meeting on Infectious Diseases (CACMID), November 7-10, 2004. Campbell, J. L., Spreitzer, J. D., Mulvey, M.R., and Canadian Hospital and Provincial Health Laboratories (J. L. Wylie is a member of the Provincial Health Laboratories team). 2004. Pulsed-field gel electrophoresis typing of methicillin-resistant Staphylococcus aureus in Canada: an exercise in the standardization of methods and nomenclature. CACMID, Regina, SK. Camus G., Boudreau S., Browne K., and Severini A (2004) Study of the type-specific antibody response to herpes simplex virus (HSV) using two-dimensional Western blotting 12th International Congress of Immunology. Montreal, July 18-23.Camus G., Boudreau S., Browne K., and Severini A. (2004) Study of the type-specific antibody response to herpes simplex virus (HSV) using two-dimensional Western blotting. American Society of Virology Annual Meeting. Montreal, July 10-14.Cao J. Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets.Cao J. Evaluation of Safety and Efficacy of MVA based recombinant SARS vaccines in ferretsCao J. Fourth World Congress on Vaccines and Immunization. Sept. 30- Oct. 3, 2004, Japan.Cao J. International Conference on SARS, one year after the first outbreak, May 8-11, 2004, Lübeck, Germany.Carpenter, M.S., A. Everton, J. Boutilier, C. Kelly and R. He. Hepatitis C viral protein NS5A interacts with the cellular adapter protein Nck2 in an SH3-dependent fashion. American Society for Virology, Davis California, USA, July 12-16, 2003. Abstract P27-13.Carrie AG, Collins DM, Harding GKM, Metge CJ, Zhanel GG. Effectiveness of Fluoroquinolones (FQ) and Trimethoprim-Sulfamethoxazole (TMP-SMX) in the Treatment of Community Acquired Pyelonephritis. Presented at the 41st ICAAC. Chicago, IL. September 22-25, 2001.
Carrie AG, Collins DM, Harding GKM, Metge CJ, Zhanel GG. Predictors of Receipt of a Fluoroquinolone (FQ) versus Trimethoprim-Sulfamethoxazole (TMP-SMX) for Treatment of Acute Pyelonephritis (PNP):An Analysis of Healthcare Claims From Manitoba, Canada. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Chan, E., Brandt, K., Horsman, G., Bastien, N., and Li, Y. (2002). Human metapneumovirus infection in Saskatchewan. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA. Cheng Z, Bose D, Jacobs H, Light RB, Duke K, Mink SN. Septic plasma attentuates the cardiac response to neural sympathetic stimulation in dogs. Am J Resp Crit Care Med 165:A172, 2002Cheng, K., X. Meng, N. Bykova, O. Krokhin, K. Coombs, W. Ens, K. Standing, and J. Wilkins. (2003). Sulfonation enhances and simplifies protein identification by MALDI-MS/MS. American Society for Mass Spectrometry, Montreal, Canada, June 8-12.Christianson S, M.R. Mulvey. A Comparative Genomic Hybridization Study of Methicillin-Resistant Staphylococcus aureus in Canada. Canadian Association for Clinical Microbiology and Infectious Diseases 72nd Conjoint Meeting on Infectious Diseases (CACMID), November 7-10, 2004. Christianson S, M.R. Mulvey. A comparative genomic hybridization study of epidemic strains of methicillin-resistant Staphylococcus aureus in Canada. 14th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Prague, Czech Republic, May 1-4, 2004 (Poster number P1012)Ciebin B, Li A, Bolesczcuk P, Wan J, Ahmed R, Clark C, Riley G, Currie A, Middleton D., Jamieson F. 2002. A major food-borne outbreak of Shigellosis in Ontario. CACMID, November 2002.Clark C, Bryden L, Terner M, Tschetter L, Spreitzer D. Distribution of Selected Virulence Genes in Selected Salmonella Serotypes.Health Canada Research Forum, Ottawa, November 2002.Clark C, Bryden L, Woodward D, Ahmed R, Misfeldt C, Terner M. Emergence of Salmonella 4,5,12:i:- in Canada and characterization of the genetic events responsible. Health Canada Research Forum, Ottawa, November 2002.Clark C, Farber J, Pagotto F, Woodward D, and the Canadian Public Health Laboratory Forum. Human infections in Canada caused by Listeria monocytogenes. Health Canada Research Forum, Ottawa, November 2002.Clark C, Flint J, Pollari F, Bryden L, Kruk T, Ahmed R, and the Canadian Public Health Laboratory Forum. Aeromonas in Canada - an Emerging Pathogen? Health Canada Research Forum, Ottawa, November 2002.Clark C, Munro J, Ng L-K. Directions for PulseNet Canada: optimizing the network. Annual Federal Food Safety and Nutrition Research Meeting, Guelph, October, 2003.Cohen EA, X-J Yao, J. Lemay, N Rougeau, M Clément, S. Kurtz, and P Belhumeur. Genetic Selection of peptide inhibitors of human immunodeficiency virus type 1 (HIV-1) Vpr. XIV International AIDS Conference, Barcelona, Spain July 7-11, 2002.Costigan A, Odek WO, Ngugi EN, Oneko M, Moses S, Plummer FA. Income generation for sex workers in Nairobi, Kenya: business uptake and behavioural change [Abstract MoPeF4129]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002.
Cullingham, K., P. Backhouse, and L.-K. Ng. 2004. Rapid Detection of SNPs Conferring Antimicrobial Resistance in Neisseria gonorrhoeae Using SNaPshot and Capillary Electrophoresis, Presentation, International Antibiotic Resistance Symposium. Winnipeg, Manitoba, June 8 2004.Cullingham, K., P. Backhouse, and L.-K. Ng. 2004. Rapid Detection of SNPs Conferring Antimicrobial Resistance in Neisseria gonorrhoeae Using SNaPshot and Capillary Electrophoresis, Abstract, American Society of Microbiology 104th General Meeting, New Orleans, Los Angeles, May 2004.Cullingham, K., P. Backhouse, and L.-K. Ng. 2004. Rapid Analysis of Antimicrobial Resistance Conferring SNP’s in Neisseria gonorrhoeae, Abstract, Canadian Student Health Research Forum, Winnipeg, Manitoba, June 7 2004.Czub M, Cao J, Gren J, Jones S, Smith G, Proulx R, Weingartl H.(2004) Susceptibility of ferrets (Mustela putorius furo) to SARS coronvirus. Presentation at23rd Annual Meeting, American Society for Virology, Montreal, Canada, July 10 - 14Dalal S, Nicolle L, Zhang L, Marrs C, Harding G, Foxman B. Long term Escherichia coli Asymptomatic Bacteriuria among 25 Diabetic Women. Presented at the 40th Annual Meeting of Infectious Diseases Society of America. Chicago, Il. October 24 – 27, 2002.Davidson RJ, Chan CK, Doern G and Zhanel GG. Macrolide-resistant Streptococcus pneumoniae in Canada: Correlation with azithromycin use. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Glasgow, Scotland 2003.Dawood MR and Smart G (2002). An alternative method other than western blot to confirm the HIV antibody screen positive specimens. The 11th Annual Canadian Conference on HIV/AIDS Research.Dawood MR, Smart G and Kaita KDE (2001). Rapid and more sensitive method for genotyping hepatitis C virus using fluorescent microspheres. (1st Canadian Conference on Hepatitis C)Dawood MR, Smart G, Forrester L, Giulivi A and Kaita KDE (2002). Seroprevalence of SEN virus among individuals at high or low risk for infection with blood-borne pathogens in Manitoba, Canada. International Conference on Emerging infectious Diseases. Atlanta, USA.De Wals P, Petit G, Erickson LJ, Guay M, Tam T, Law B, Framarin A. Benefits and costs of immunization of infants with pneumococcal conjugate vaccine in Canada. Canadian National Immunization Conference, Victoria, B.C. Dec1-3, 2002. Poster AttDeCorby M, Palatnick L, Laing N, Wierzbowski AK, Nichol K, Hoban DJ, and Zhanel GG. Susceptibility of Haemophilus influenzae to macrolides and ketolides: Results of the Canadian Respiratory Organisms Susceptibility Study (CROSS) 1997-2002. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Halifax, Nova Scotia, November 2002.DeCorby MR, Harris RLC, Nichol KA, Noreddin AM, Hoban DJ, Zhanel GG. Pharmacodynamic (PD) activity simulating free epithelial lining fluid (ELF) concentrations of macrolides and ketolides against macrolide hypersusceptible Haemophilus influenzae using an in vitro model. American Society for Microbiology (ASM), Washington, DC, May 2003.Deeks S, Clark M, Scheifele D (for members of IMPACT), Law B (for members of ACCA), Dawar M, Walop W, King A. A review of adverse events associated with BCG vaccine in Canada. American Public Health Association 131st Annual Meeting, San Francisco, CA. Nov, 2003. Poster NA
Dibernardo A, Drebot MA, Lindsay R, Andonova M, Artsob H, Maranan L, Barker I, Buck P, and Sockett P. (2002) Laboratory-based surveillance for West Nile virus activity in Canada. National surveillance for West Nile virus in Canada. Health Canada Research Forum: From Science to Policy, November 18-19, Ottawa, Ontario.Dibernardo A, Lindsay R, Artsob, H, Canz A, Weingartl H, Bird D, Drebot M.(2004) Evaluation of a competitive enzyme-linked immunosorbent assay (ELISA) for the detection of serum antibodies to West nile virus (WNV). Presentation at CACMID 2004, Regina, Canada, November 7 - 10.Dobson S, Duval B, Law B, Diaz-Mitoma F, Sharfran S, Dubin G, Collard F. Safety and immunogenicity of a prophylactic genital herpes vaccine formulated glycoprotein D2 and AS04 adjuvant in preteens, adolescents and adults. ISSTDR annual Meeting, Canada. Nov 2003Dore, K., Demczuk, W., Mulvey, M. R., Ng, L. K., Ahmed, R., Dutil, L., and CIPARS Partnership (J. L. Wylie is a member of the CIPARS partnership). 2004. Antimicrobial Resistance patterns of Salmonella identified in Canada: 2003. CACMID, Regina, SK. Doublet B. , R. Lailler, D. Meunier, A. Brisabois, D. Boyd, M.R. Mulvey, E. Chaslus-Dancla, A. Cloeckaert Identification d’un variant du locus de multirésistance de l’îlot génomique de Salmonella SGI1 chez Salmonella enterica serovar Albany. 2002.Doublet, B., Butaye, P., Imberechts, H., Boyd, D., Mulvey, M.R., Chaslus-Dancla, E., Cloeckaert, A. Characterization of Salmonella genomic island 1 multidrug resistance gene clustes from S. enterica serovar agona, Belgium, 1992-2002. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.Douville, R.N., K. Coombs, F.E.R. Simons, and K.T. Hayglass. (2002). Prevalence of a reovirus specific immune response in a human population. Canadian Society for Allergy and Clinical Immunology, Québec City, Sept. 7-12.Drebot M, Burbidge E, Artsob H. 2003. Phylogenetic characterization of snowshoe hare (SSH) virus isolates from across Canada. XII International Conference on Negative Strand Viruses, June 14-19, Pisa, Italy.Drebot M, Doyle J, Holloway K, Malan S, Artsob H, Prasad E. 2001. Identification of an imported case of hantavirus pulmonary syndrome (HPS) from Argentina. Canadian Association for Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.Drebot M, Lindsay R, Galloway T, Dibernardo A, Artsob H, Trudel L, Barker I. 2002. Detection and genetic characterization of granulocytic ehrlichae from Ixodes scapularis and ticks collected in various provinces in Canada. IX International Conference on Lyme Borreliosis and other Tick-Borne Diseases, August 18-22, New York, New York.Drebot M, Pasik J, Munroe F, Sabara M, Richt J, Artsob H. 2001. Bornavirus infection of horses from Nova Scotia and Manitoba. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Drebot MA, Andonova M, Barker I, Lindsay R, Weingartl H, Buck P, Sockett P, Artsob H. 2002. Employing an avian surveillance program for the detection of West Nile virus in Canada: 2001-2002. Canadian Association for Clinical Microbiology and Infectious Diseases, November 3-6, Halifax, Nova Scotia.Drebot MA, Barker I, Lindsay R, Buck I, Weingartl H, Hunter F, Ebel G, Kramer L, Lanciotti R, Sockett, Artsob H. 2002. The incursion of West Nile virus into Canada in 2001.
International Conference on Emerging Infectious Diseases 2002, March 24-27, Atlanta, Georgia.Drebot MA, Barker I, Lindsay R, Weingartl H, Buck P, Sockett P, Artsob H. 2001. The emergence of West Nile virus into Canada in 2001. Canadian Association for Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.Drebot MA, Burbidge E, Artsob H. 2002. The genetic characterization of snowshoe hare virus strains from across Canada. International Conference on Emerging Infectious Diseases 2002, March 24-27, Atlanta, Georgia.Drebot MA, Doyle J, Holloway K, Malan S, Artsob H, Prasad E. 2001. First laboratory confirmed case of hantavirus pulmonary syndrome (HPS) imported from Argentina to Canada. Annual Meeting of the American Society of Tropical Medicine and Hygiene, November 11-15, Atlanta, Georgia.Drebot MA. (2001). Using molecular diagnostics for determining transmission pathways for zoonotic pathogens. Medical Microbiology and Infectious Diseases Retreat 2001, June 29-July1. Gull Harbour Resort, Manitoba.Embil JM, Goulet S, Martin B, Koulack J, Fong H, Duerksen F, Simonsen N, Nicolle L. Lower Extremity Re-vascularization for Peripheral Vascular Disease: An Outcome Analysis. 4th International Symposium on the Diabetic Foot. Noordwijkerhout, The Netherlands, May 23, 2003.Embil JM, Reid K, Martin B, Nicolle L, Duerksen F, Simonsen N. Lower Extremity Complications of Diabetes in a Northern Canada First Nations Community: Burden of Illness and Parameters of Care. 9th Malvern Diabetic Foot Conference. Malvern, Worchestershire, United Kingdom, May 16, 2002.Farber, J.M., F. J. Pagotto, E. Daley, S. Kopil, A. Hughes, J. Drew, J. L. Wylie, S. Giercke, D. Nowicki, S. Harlos, G. Hammond, and J. Kettner. 2001. A point-source outbreak of Listeria monocytogenes linked to whipping cream. ISOPOL XIV - International Symposium on Problems of Listeriosis.Fatoye, A., Bow, E.J., Loewen, R.: Amphotericin B Lipid Complex (ABLC) and Caspofungin as combination therapy for disseminated Fusariosis in a patient with acute myeloid leukemia (AML). ISHAM, Abstract #392, San Antonio, Texas, May 25-29, 2003.Fearon M, Artsob H, Drebot M, Andonova M, Chiang W, Simmons P, ChenSee G, Papageorgiou L, Cheung E, George P, Guglielmi L, Rau,N, Shapiro H, Nosal B, Finkelstein M, Heimann A, leBer C, Middleton D. 2002. A report on the first human cases of endemic West Nile infection in Canada. Canadian Association for Clinical Microbiology and Infectious Diseases,November 3-6, Halifax, Nova Scotia.Fearon M, Middleton D Artsob H, Drebot M, Andonova M, Chiang W, Simmons P, ChenSee G, Papageorgiou L, Cheung E, George P, Guglielmi I, Rau N, Shapiro H, Nosal B, Finkelstein M, Heimann A,. 2003. A report on the first human cases of endemic West Nile infection in Canada. Annual Meeting of the American Society of Microbiologists, May 18-22, Washington, DC.Galloway TD, Lindsay LR, Dibernardo A, Artsob H. 2001. Dogs and cats as sentinels for blacklegged ticks, Ixodes scapularis (Acari: Ixodidae), in Manitoba, a non-endemic area of central Canada. International Conference on Ectoparasites of Pets, Westport, May, Co. Mayo, Ireland. P 97.Galloway TD, Lindsay LR, Dibernardo A, Artsob H. 2001. Surveillance for blacklegged ticks, Ixodes scapularis (Acari:Ixodidae), in Manitoba, a non-endemic area of central Canada.
International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Gartner, J.G., Ellison, C.A., Natuik, S.A., Fischer, J.M.M., Bow, E.J., Scully, S.A. Recombinant Human Keratinocyte rowth Factor (rHuKGF) Exacerbates Renal Pathology in a Murine Model of Chronic Graft-vs-Host Disease (GVHD). ASH, Abstract #3539, San Diego, California, December 8, 2003. . Blood 2003; 102 (11) Abstract #3539, p. 950a.Gelmon LJ, Makokha J, Chirchir B, Hayman J, Kieffer MP, Ilinigumbo A, Bwayo JJ; HIV/AIDS Training Needs Assessment in Eastern and Southern Africa; presented at the XIIIth International Conference on AIDS/STDs in Africa, Nairobi, Kenya, September 2003; Abstract 936107, Abstract volume, pg. 283
Gelmon LJ, Ndiritu A, Makokha J, Bwayo JJ; Regional AIDS Training Network – Five Years of Progress; presented at the XIIth International Conference on AIDS/STDs in Africa, Ouagadougou, Burkina Faso, December 2001; Abstract 10PT1-21, Abstract volume pg. 43
Gelmon LJ, Ndiritu A, Mbogoh P, Makokha J, Bwayo JJ, Plummer F; Regional AIDS Training Network – A Canadian-Led Initiative for Capacity-Strengthening in Africa; presented at the XIth Canadian Conference on HIV/AIDS Research, Winnipeg, Canada, April 2002; Abstract 426P, Canadian Journal of Infectious Diseases, March/April 2002, Vol 13 Suppl A: 77A Gelmon LJ, Ndiritu A, Mbogoh-Nayamu P, Makokha J, Bwayo JJ; The Regional AIDS Training Network (RATN): An African Success Story; presented at the XIIIth International Conference on AIDS/STDs in Africa, Nairobi, Kenya, September 2003; Abstract 740782, Abstract volume, pg. 210
Gelmon LJ, Ndiritu A, Mbogoh-Nayamu P, Makokha J, Bwayo JJ; The Regional AIDS Training Network (RATN): A Successful Model for Best Practices in Capacity Development; presented at the XIVth International AIDS Conference, Barcelona, Spain, July 2002; Abstract WePeE6472, Abstract Vol 2, pg. 204
Gelmon LJ; The Regional AIDS Training Network: A Model for International Collaboration; presented Intl Conf on Best Practices in Training, Lessons Learned and Future Directions, Washington DC, May 2002Gottlieb K, Drebot MA, Lindsay R, Hjelle B. (2002). A molecular marker appropriate for the identification of blood meals of arboviral vectors. 51st Annual Meeting, American Society of Tropical Medicine and Hygiene, November 10-14, Denver, Colorado.Goulet S, Martin B, Koulack J, Fong H, Duerksen F, Simonsen N, Nicolle L, Embil JM. Lower Revascularization for Peripheral Vascular Disease: An Outcome Analysis. Submitted, Annual Session, American College of Physcians Annual General Meeting, April 22-24, 2004.Gradišnik L, Jakobsen M, Weingartl, H, Cencic A. (2004) Biological assay to study antiviral properties of probiotic bacteria. Poster at “INRA-RRI, 2004: Gut microbiology. Concerns and responses to food safety, health and environmental issues. Clermont-Ferrand, France, June 21 - 23.Gravel D, Matlow A, Canadian Nosocomial Infection Surveillance Program and Canadian CANADIAN HOSPITAL EPIDEMIOLOGY COMMITTEE (Mulvey M, Embil J, and Embree J, Members). Nosocomial infections identified during a point prevalence survey within selected Canadian healthcare institutions. Annual Conference, Community and Hospital Infection Control Association - Canada, Thunder Bay, ON, June 23-26,2003.Grose C, S Tyler, G Peters, J Hiebert, GW Stephens, WT Ruyechan, W Jackson, J Storlie and GA Tipples. Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: Evolution of genotypes with
an accelerated cell spread phenotype. 29th Annual International Herpesvirus Workshop, Reno, Nevada, July 25-30, 2004.Grudeski E., L.Lin, M Traykova-Andonova, M. Drebot, M. Gallard and A. Andonov; “Quantitative TaqMan RT-PCR Test for SARS Coronavirus (SARS-CoV)”. 72nd Annual CACMID (Canadian Association for Clinical Microbiology and Infectious Diseases) Meeting, November 2-5, 2003, Montreal. Gubbins, M., Johnstone, D., Tsang, R., Yuan, X., Plummer, F., and J.D. Berry. (2003) Immunogenetic characterization of neutralizing murine mAbs to the human SARS-Coronavirus (SARS-hCoV). IBC Antibody Engineering, San Diego, Dec. 1-4th. Guglielmi I, Fearon M, Leber C, Ford-Jones L, Alves D, Barker I, Rosatte R, Lindsay R, Heal J, Cutten G, Artsob H. 2001.Canadian Association for Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.Halayko, S., Kubay, J., Gren, J., Copps, J., Weingartl, H., and Lindsay, R. (2002) Housing and care of the Common Crow in Biosafety Level 3. CALAS, Edmonton, June 21 - 26Halperin SA, Langley JM, Boucher FD, Smith B and PICNIC Investigators (B. Law was the PICNIC site investigator for Winnipeg). Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Poster, 40th annual meeting, Infectious Diseases Society of America. Oct 24-27, 2002. Chicago, Illinois. AttHan X. and X. Yang. Adoptive transfer of dendritic cells from chlamydia infected inhibits allergic responses induced by ovalbumin. Nov 2002, Quebec city, QuebecHan X. and X. Yang. Chlamydia trachomatis infection allergic reaction in a mouse model of asthma. April 2001, Banff, AlbertaHan X. and X. Yang. Role of dendritic cell in chlamydial infection mediated inhibition of allergic reaction. World of Allergy, Vancouver, September, Allergy Cin Immunol Int, suppl p66, 2003Han X., S. Wang, Y. Fan, L. Jiao, J. Yang, X. Yang. IL-10 and IL-12 production by dendritic cells from chlamydia-infected mice play an important role in the inhibition of allergic response to ovalbumin. CIM 27:134A, 2004Harding GKM, Robson D, Davi M, Bernard K, Van Caeseele P, Alfa MJ. A Necrotizing Enterocolitis Outbreak associated with a novel Clostridium species in a Neonatal Intensive Care Unit. Presented at the 12th International Symposium on Infections in the Immunocompromised Host. Bergen, Norway. June 23–26, 2002.Harding, G.K.M., Zhanel, G.G., Nicolle, L.E., Cheang, M. Should asymptomatic bacteriuria be treated in women with diabetes? Abstract L-1796 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, Sept 30, 2002.Hazelton, P.R., K.M. Coombs, T.B. Ball, L. Klass, D. Milley, and P. Plourde. (2001). Duration of Calicivirus Shedding and Viral Load in Patients During a Long Term Care Hospital Outbreak. Roche Light-Cycler Conference, Winnipeg, Oct. 19.Hazelton, P.R., MacDonald, A., Nowicki, D., Wylie J. L., Milley, D. Stratton, J., Coombs, K. M., Carpenter, M. S., Drew, J. Hammond, G. W. 2004. Environmental RT-PCR to identify and confirm the mechanism of infection in a prolonged outbreak of calicivirus gastroenteritis at a resort. American Society of Virology, Montreal, CA.He, R. Nov. 2004. CACMID conference. Inhibition effect of ATA on SARS-CoV and other viruses.
He, R. Oct. 2004. Health Canada Science Forum. Inhibition effect of ATA on SARS-CoV replicationHe, R. Oct. 2004. Health Canada Science Forum. Self-mumtimerization of SARS-CoV nucleocapsid proteinHe, R. Oct. 2004. Third international Conference on Human Proteome Organization. Interaction between SARS-CoV nucleocapsid protein and ribosomal proteins.Heaman, M., A. Elliott, J. Wylie, A. Jolly, M. Ormond, and M. Dawood. 2002. The Winnipeg Social Network Injection Drug Use Study: focus group results. 11th annual conference on HIV/AIDS research, Winnipeg, Manitoba. Hermann, L., and K.M. Coombs. (2001). Molecular characterization of T2W a novel reovirus. American Society for Virology, University of Wisconsin-Madison, July 21-25.Hermann, L., and K.M. Coombs. (2002). Characterization of potential novel reovirus: T2W. Young Investigators Forum (Canadian Society of Clinical Investigators), Ottawa, Sept. 26. (also published in Clinical and Investigative Medicine 25:155-156.)Hermann, L.L., and K.M. Coombs. (2004). The effects of mycophenolic acid on a novel reovirus clone. Western Student Medical Forum, Carmel, California, Jan. 28-31.Hill C, Rahn K, Franklin K, Clark C, Fields P, McQuiston J, Taboada E, Nash J, Muckle A, Cole L, Wilkie B, Sturrock D. Design of a microarray for DNA-based serotyping of Salmonella. Annual Federal Food Safety and Nutrition Research Meeting, Ottawa, October, 2003.Hisanaga, TL, DeCorby MR, Laing NM, Nichol KA, Palatnick LP, Johnson J, Harding GKM, Noreddin A, Hoban DJ Zhanel GG, the NAUTICA Group. Antibiotic Resistance in Inpatient Urinary Isolates: Results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Presented at the 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, IL. September 14 – 17, 2003.Hoban D, Witwicki E, Zhanel G, Dugourd D. In vitro resistance development of MBI 226 to clinically relevant bacteria. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Hoban DJ, Bellyou T, Palatnick L, Nichol K and Zhanel GG. GAR-936 (GAR) demonstrates potent in-vitro activity against multi-drug resistant Streptococcus pneumoniae. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Hoban DJ, Nichol K, Palatnick L, Gin A, Low D The Canadian Respiratory Organism Susceptibilty Study (CROSS) and Zhanel GG. Decreasing incidence of penicillin non-susceptible Streptococcus pneumoniae (SPN) in Canada: Results of an ongoing national surveillance study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Hoban DJ, Palatnick L, Nichol K and Zhanel GG. Linezolid (LIN) Demonstrates Potent In Vitro Activity Against Multi-Drug Resistant S. pneumoniae (SPN) in Canada 1998-2001. International Conference on Macrolides Azalides Streptogramins Ketolides and Oxazolidinones (ICMASKO), Bologna, Italy, January 23-25, 2002. Hoban DJ, Palatnick L, Weshnoweski B, Nichol K and Zhanel GG. Comparative activity of MK-0826 (Ertapenem) against Canadian respiratory isolates of Streptococcus pneumoniae (SPN) and Haemophilus influenzae (HI). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.
Hoban DJ, Palatnick L, Wierzbowski A, Bellyou T, Nichol K and Zhanel GG. Activity of telithromycin and oral comparators against 14,199 Canadian respiratory tract pathogens isolated from 1997-2001. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Hoban DJ, Weshnoweski B, Bellyou T, Palatnick L, and Zhanel GG. Azole resistance in Candida Aspergillus and Penicillium species: Results of a three year Canadian national surveillance study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Hoban DJ, Witwicki E, Zhanel GG, Palatnick L, Friedland D. In vitro Activity of the Novel Cationic Peptide MBI 226 Against 750 Clinical Isolates. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Hoban DJ, Aoki F, Palatnick L, Nichol K and Zhanel GG. Discordance in antibiotic resistance between bacteremic and respiratory isolates of Streptococcus pneumoniae: Results of a 3 Year (1999-2002) Manitoba Bacteremic/Respiratory Organism Surveillance Study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Hoban DJ, Bellyou T, Palatnick L, Nichol K, Zhanel GG. GAR-936 (GAR) demonstrates potent in vitro activity against multi-drug resistant Streptococcus pneumoniae. Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 2001.Hoban DJ, Bellyou T, Palatnick L, Nichol K, Zhanel GG. Tigecycline (GAR-936) demonstrates potent in vitro activity against multi-drug resistant Streptococcus pneumonoiae. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 2002.Hoban DJ, Bouchillon SK, Johnson JL, Stevens T, Johnson BM. The impact of CO2 on Etest telithromycin (TEL) MICs: Results of an NCCLS M23 type study. American Society for Microbiology (ASM), New Orleans, Louisiana, May 2004.Hoban DJ, Felmingham D. Pediatric vs. adult patients with community-acquired respiratory tract infection: Resistance surveillance over 3 years (PROTEKT 1999-2002). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Hoban DJ, Hisanaga TL, DeCorby MR, Laing NM, Nichol KA, Palatnick L, Hawser S, Islam K and Zhanel GG. In vitro activity of Iclaprim (formerly AR-100) against lower gastrointestinal tract isolates. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Montreal, Quebec, November 2003.Hoban DJ, Nichol K, Palatnick L, Gin AS, Low D, The Canadian Respiratory Organism Susceptibility Study (CROSS), Zhanel GG. Decreasing incidence of penicillin non-susceptible Streptococcus pneumoniae (SPN) in Canada: Results of an ongoing national surveillance study. Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 2001.Hoban DJ, Nichol KA, Swedlow D, Wierzbowski AK, Palatnick LP, Smith HJ, Mulvey M, Zhanel GG. Incidence of MefA and ErmB among macrolide non-susceptible Streptococcus pneumoniae (SPN) isolated in Canada in 2001. International Congress of Chemotherapy (ICC), Durban, South Africa, June 2003.Hoban DJ, Noreddin A, Roberts D, Laing N, Nichol K, Wierzbowski A and Zhanel GG. Pharmacodynamic modelling of the novel ketolide telithromycin versus PCR-positive mefA and ermB macrolide-resistant strains of Streptococcus pneumoniae using an in-vitro model. International Congress and Infectious Diseases (ICID) , Singapore, March 11-14, 2002.
Hoban DJ, Palatnick L, Bellyou T, Karlowsky K, Nichol K, Smith H, Hoban C, and Zhanel GG. Activity of telithromycin and oral comparators against 7153 Streptococcus pneumoniae isolated in Canada from 1997-2003. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2003.Hoban DJ, Palatnick L, Bellyou T, Rimmer E, Nichol K, and Zhanel GG. Comparative Activity of MK-0826 (Ertapenem) Against Canadian Respiratory Isolates of Streptococcus pneumoniae (SPN) and Haemophilus influenzae (HI). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Hoban DJ, Palatnick L, Bellyou T, Rimmer E, Nichol K, Hoban C, Zhanel GG. Ertapenem is highly active against respiratory and bacteremic S. pneumoniae (SPN) isolated in Canada (1999-2003). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Hoban DJ, Palatnick L, Nichol K and Zhanel GG. Activity of fluoroquinolones vs. respiratory pathogens. International Fluoroquinolone Meeting, Edinburgh, Scotland, 2001.Hoban DJ, Palatnick L, Nichol K and Zhanel GG. Activity of telithromycin and oral comparators against 16,896 Canadian respiratory tract pathogens isolated from 1997-2002. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Hoban DJ, Palatnick L, Nichol K and Zhanel GG. Gemifloxacin is the most active fluoroquinolone against Canadian respiratory tract isolates. International Congress of Chemotherapy (ICC), Amsterdam, 2001.Hoban DJ, Palatnick L, Nichol K and Zhanel GG. Tigecycline (GAR-936) demonstrates n potent activity against multi-drug resistant S.peumoniae. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Hoban DJ, Palatnick L, Noreddin A, Smith H, Nichol K, Zhanel GG. Garenoxacin is active against Canadian lower respiratory tract infections (RTI) pathogens isolated from 1999-2003. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Hoban DJ, Palatnick L, Smith H, Nichol K, Hoban C and Zhanel GG. Activity of BMS284756 and Marketed Fluoroquinolones Against Lower Respiratory Tract Pathogens: Results of a 3 Year Canadian Surveillance Study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Hoban DJ, Palatnick L, Smith H, Nichol K, Wierzbowski A, Zhanel GG. Telithromycin demonstrates potent activity against multi drug resistant S. pneumoniae isolated from pediatric patients in Canada during 1997-2002. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 2002. Hoban DJ, Palatnick L, Wierzbowski A, Bellyou T, Nichol K, Hoban C, Zhanel GG. Activity of telithromycin and oral comparators against 17,053 Canadian respiratory tract pathogens isolated from 1997-2002. International Congress of Chemotherapy (ICC), Durban, South Africa, June 2003.Hoban DJ, Palatnick L, Zhanel GG, Sitar D, Garber G. Telithromycin does not alter oropharyngeal flora of healthy subjects. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Hoban DJ, Palatnick L, Zhanel GG, Sitar D, Sequin I, Cote D, Garber G. Effect of multiple dose treatments with telithromycin in comparison to azithromycin moxifloxacin and
ciprofloxacin on normal fecal flora of healthy subjects. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Montreal, Quebec, November 2003.Hoban DJ, Palatnick LP, Wierzbowski A, Bellyou T, Nichol K, Zhanel GG. Activity of telithromycin and oral comparators against 16,896 Canadian respiratory tract pathogens isolated from 1997-2002. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 2002.Hoban DJ, Weshnoweski B, Bellyou T, Rimmer E, Palatnick L, and Zhanel GG. Azole Resistance in Candida, Aspergillus & Penicillium species: Results of a Four Year Canadian National Surveillance Study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Hoban DJ, Weshnoweski B, Bellyou T, Rimmer E, Palatnick L and Zhanel GG. Azole resistance in Candida Aspergillus and Penicillium species: Results of a five year Canadian national surveillance study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2003.Hoban DJ, Weshnoweski B, Bellyou T, Rimmer E, Palatnick L, Zhanel GG. Azole resistance in Candida, Aspergillus & Penicillium species: Results of a five year Canadian national surveillance study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Hoban DJ, Wierzbowski A, Palatnick L, Nichol K and Zhanel GG. Telithromycin demonstrates potent activity against multi-drug resistant S.pneumoniae isolated from pediatric patients. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Hoban DJ, Wierzbowski A, Zhanel GG. Activity of telithromycin against 215 erythromycin resistant (ERY-R) Streptococcus pneumoniae (SPN) isolated in Canada during 1998 and 1999. East Asian Congress on Infectious Diseases , Hong Kong, December 12, 2001.Hoban DJ, Witwicki E, Zhanel GG, Workman L, Clement J, Friedland HD and Dougard D. In vitro resistance development of clinically relevant bacteria to omiganan pentahydrochloride. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2003.Hoban DJ, Zhanel GG. Activity of gemifloxacin and comparative fluoroquinolones (FQ) against isolates of Streptococcus pneumoniae (SPN) with reduced susceptibility to ciprofloxacin. East Asian Congress on Infectious Diseases , Hong Kong, December 12, 2001.Hodkinson, R., K. Multatz, L. Ng., J. Wylie, T. Vinayagamoorthy. 2003. Simultaneous genotyping of sexually transmitted bacterial pathogens using MULTIGEN Technology. International Society Sexually Transmitted Disease Research Congress. Ottawa, Canada. Humar A, D Kumar, D Safronetz and G Tipples. An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes. American Transplant Congress, Boston, May 15-19, 2004.Hutmacher M, Law B, Scheifele D, Halperin S and members of IMPACT. Hospital admissions for BCG Vaccine complications: IMPACT hospitals, 1993-2001. Canadian National Immunization Conference, Dec 1-3, 2002; Victoria, BC. Poster. PresIqbal SM, Ball TB, Kiama P, Kimani J, Fowke KR and Plummer FA. Alterations in the t-cell population of the cervical mucosa in HIV-resistant sex workers. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada. Isaacs S, Aramini J, Ceibin B, Farrar J, Ahmed R, Middleton D, Howes M, Chan E, Pichette S, Campbell K, Mead P, Lior LY, Pearce M, Clark C, Rodgers F, Jamieson F, Brophy I, Ellis A.
Response to an outbreak of Salmonellosis associated with California almonds. International Association for Food Protection, 2002.Jassal R, Jassal D, MacDonald K, Hitchon C, Embil J. Hemorrhagic Cholecystitis in a Patient with Sjogren’s Syndrome. American College of Physicians – Annual Session, Philadelphia, PA, April 12, 2002.Jassal R, Jassal D, Moltzan C, Embil J. Acute Thrombocytopenic Purpura Complicating Varicella-zoster Virus Infection in Adults. American College of Physicians – Annual Session, Philadelphia, PA, April 12, 2002.Jiang, J., and K Coombs. (2002). Temporal patterns of p53-dependent and p53-independent apoptosis during reovirus infection. Canadian Society for Microbiology, University of Saskatchewan, Saskatoon, June 16-19.Jiao L. and X. Yang. Inactivated bacterial exposure in early life has long-term effect on allergic responses possibly through modulating dendritic cell (DC) function. CIM 27:138A, 2004Jiao L. and X. Yang. Early exposure to bacterial products inhibits the development of allergic reaction. World of Allergy, Vancouver, September, Allergy Cin Immunol Int, suppl p146, 2003Johnson B, Stevens T, Bouchillon S, Johnson J, Hoban D, Gaylord C, Hackel M, McCarthy M, Person M. Tigecycline in vitro antibacterial activity against isolates of non-enterobacteriaceae. International Congress on Infectious Diseases (ICID), Cancun, Mexico, March 2004.Johnson B, Stevens T, Bouchillon S, Johnson J, Hoban D, Gaylord C, Hackel M, McCarthy M, Person M, Dowzicky M. In vitro activity of Tigecycline (GAR-936) against 275 clinical isolates of Enterococcus faecium: Potent VRE activity. International Congress on Infectious Diseases (ICID), Cancun, Mexico, March 2004.Johnson B, Stevens T, Bouchillon S, Johnson J, Hoban D, Gaylord C, Hackel M, McCarthy M, Person M. Tigecycline in vitro antibacterial activity against 1,499 isolates of enterobacteriaceae. International Congress on Infectious Diseases (ICID), Cancun, Mexico, March 2004.Johnson B, Stevens T, Bouchillon S, Johnson J, Hoban D, Gaylord C, Hackel M, McCarthy M, Person M. Tigecycline in vitro antibacterial activity against 249 methicillin resistant and 250 methicillin sensitive Staphylococcus aureus isolates. International Congress on Infectious Diseases (ICID), Cancun, Mexico, March 2004.Johnson B, Stevens T, Hoban D, Bouchillon S, Johnson J, Gaylord C, Hackel M, McCarthy M, Person M. DRF 11057 a novel oxazolidinone, in vitro activity against community acquired pneumoniae (CAP) pathogens globally isolated from 1999-2002. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Prague, Czech Republic, May 2004.Johnson B, Stevens T, Hoban D, Bouchillon S, Johnson J, Gaylord C, Hackel M, McCarthy M, Person M. DRF 11057 a novel oxazolidinone, in vitro activity against methicillin susceptible and resistant S. aureus, S. epidermidis and vancomycin resistant E. faecium. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Prague, Czech Republic, May 2004.Johnston L, M Ofner-Agostini, D Gravel, J Conly, A Simor, A Matlow, J Embil, M Mulvey, S Paton, Canadian Hospital Epidemiology Committee (CHEC), and Canadian Nosocomial Infection Surveillance Program (CNISP). Vancomycin-Resistant Enterococci (VRE) in Canadian Health Care Facilities: 5 Years of Prospective Surveillance (1998-2003). IDSA (Sept.
30-Oct. 3, 2004), Boston MA.
Johnston L, Ofner-Agostini M, Conly J, Simor A, Matlow A, Embil J, Mulvey M, Paton S, CANADIAN HOSPITAL EPIDEMIOLOGY COMMITTEE (Mulvey M, Embil J, and Embree J, Members) , Canadian Nosocomial Infection Surveillance Program. Infection control strategies to prevent the transmission of vancomycin-resistant enterococci (VRE) in hospitals participating in the Canadian Nosocomial Infection Surveillance Program. 14th Annual Scientific Meeting of The Society for Healthcare Epidemiology of America. Philadelphia, PA, April 17-20,2004.Kabani, A., Nagata, L., Masri, S., Tsang, R., and J.D. Berry. 2004. The Development of Recombinant Monoclonal antibodies for treatment and detection of BioThreat Agents. CRTI Symposium, June 15-16, Gatineau, Quebec.Kays MB, Denys GA, Hoban DJ. Impact of new and proposed MIC breakpoint changes on the in vitro activity of penicillin and ceftriaxone against non-meningeal isolates of Streptococcus pneumoniae. American College of Clinical Pharmacy Annual Meeting, Albuquerque, New Mexico, October 2002. Kimani J, Kaul R, Ngugi EN, Bwayo JJ, Fonck K, MacDonald KS, Temmerman M, Moses S. A randomized, placebo-controlled trial of monthly azithromycin to prevent sexually transmitted infections (STI) and HIV in Kenya female sex workers (FSWs) [Abstract TuOrD1151]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002King SM, Jorbes J, Singer J, Lapointe N, Samson L, Embree J, Vaudry W. Survival of perinatally HIV-infected children in Canada. Fourteenth International AIDS Conference, Barcelona, Spain July 7-12, 2002 (Abstract # ThOrC1447).King SS, Singer J, Forbes J, Lapointe N, Samson L, Vaudry W, Embree J, The Canadian Pediatric AIDS Research Group. Survival of perinatally HIV-infected children in Canada. Eleventh Annual Canadian Conference on HIV/AIDS Research (CAHR), Winnipeg, Canada; April 25-28, 2002. (Abstract # 367P)Klass, L., Kennedy, J., MacFarlane, N., Robson, D., Nicolle, L. Outbreak of viral gastroenteritis in a tertiary care hospital. Community and Hospital Infection Control Association (CHICA-Canada) National Educational Conference, June 24, 2003, Thunder Bay, Ontario.Knox J. David, Ron. E. Mitchel, Douglas R. Boreham: Radiation-Induced Protection from Prion Disease. European Network of Excellence First Annual International Conference about Prion Disease. Pasteur Institute, Paris, May 2004.Koesters S, Matu L, Kiama P, Kimani J and Fowke KR Differences in Immune Activation Levels Between Populations: Considerations for Vaccine Preparedness. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada.Koesters S, Matu L, Kiama P, Kimani J, and Fowke KR. Immune Activation in Distinct Populations: Implications for Vaccine Efficacy. Canadian Student Health Research Forum Manitoba Health Research Poster Competition. May 13, 2003, Winnipeg, Canada, Abstract # 56. Canadian Student Health Research Forum: Manitoba Health Research Poster Competition Award
Koesters S, Tipples G, Gray M and Fowke KR. Active HHV-6 Infection Does Not Correlate with HIV Disease Progression in a Kenyan Commercial Sexworker Cohort. Canadian Association for HIV Research Annual Meeting April 25-28 2002, Winnipeg, Canada.
Koesters SA, Wachichi C, Matu L, Kimani J, Embree J, Plummer FA, and Fowke KR. Decreased Expression of IL-7R is Associated with HIV Disease Progression. Canadian Student Health Research Forum Manitoba Health Research Poster Competition. June 8, 2004, Winnipeg, Canada, Abstract # 76. Canadian Student Health Research Forum: Manitoba Health Research Poster Competition Award
Kozyrskyj AL, Carrie AG, Law BJ, Mazowita GB, Klassen TP, Hammond G. Decrease in antibiotic use among Canadian children in the 1990’s, but not for all antibiotics [oral presentation]. Canadian Pediatric Society, Toronto, June 2002 NAKozyrskyj AL, Dahl M, Law BJ, Chateau D, Mazowita GB, Klassen TP. Physician and household determinants of inappropriate antibiotic use in children. Canadian Association for Population Therapeutics Annual Meeting, March, 2003. NAKozyrskyj AL, Law BJ, Becker AB Antibiotic Treatment of Asthma Exacerbations in Children: What is the Practice? [poster presentation] Canadian Society of Allergy & Clinical Immunology Annual Meeting, Quebec City, November 2002 NALangley J, Embree J, Matlow A, Moore D, Conly J, Gravel D, Paton S, Mulvey M. Cerebrospinal fluid shunt associated infections- a Canadian Hospital Epidemiology (CHEC) and Canadian Nosocomial Infection Surveillance Program (CNISP) prospective cohort study. 11th International Conference of the Society for Healthcare Epidemiology of America, Toronto, ON 2001.Langley J, Gravel D, Paton S, CANADIAN HOSPITAL EPIDEMIOLOGY COMMITTEE (Mulvey M, Embil J, and Embree J, Members) and CNISP. Surveillance for cerebrospinal fluid (CSF) shunt associated infections (Ni) - Canadian Nosocomial Infection Surveillance Program (CNISP). 12th Annual Scientific Meeting, Society for Healthcare Epidemiology of America. Salt Lake City, UT, April 6-9, 2002.Langley, J.M., Gravel, D., Embree, J., Matlow, A., Moore, D., Conly, J., Mulvey, M., Paton, S. Surveillance for Nosocomial Cerebrospinal Fluid (CSF) shunt associated infections (NI) - a multicentre Canadian hospital prospective cohort study. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, British Columbia, Nov. 4-7, 2001.Law B and members of the Canadian Association for Immunization Research and Evaluation with Grenier D for the Canadian Pediatric Society. A Canadian residents vaccine training program: first steps. Canadian National Immunization Conference, Dec 1-3, 2002; Victoria, BC. Oral . Pres.Law B, Scheifele D, Halperin D for Members of the CPS/Health Canada Immunization Monitoring Program, Active (IMPACT), Ottawa, ON, Canada. Missed Opportunities for Varicella Prevention, 2000-2002. Oral Presentation, 81st Annual Canadian Pediatric Society Conference, Montreal, June, 2004. PresLaw B., D. Parison, J. Sampalis and members of PICNIC. Hospitalization for RSV respiratory Tract Infection of Canadian Infants born between 33 and 35 completed weeks of gestation. Poster presentation at 3rd International RSV Symposium, “RSV after 45 years”, Segovia, Spain Oct 1-3, 2001 PRESLaw BJ and members of PICNIC, Michaliszyn AF, Sampalis JSS. Risk Factors for Respiratory Syncytial Virus Lower Respiratory Tract Infection Hospitalizations (RSV-LRTI-HSP) in Premature Infants of 33 to 35 Weeks Gestation (GA33-35). Oral presentation at the 41st annual meeting, Infectious Diseases Society of America. Oct 9-12, 2003. San Diego, California. Pres Leighton FA, Artsob H, Chu MC, Olson JG. 2001. A serological survey of rural dogs and cats on the southwestern Canadian prairie for zoonotic pathogens. International Northwest
Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Li. Y., Bastien. N., Ward. D., Tam. T., Van Caeseele. P., Brandt. K., Lee. S., Chan. E., and McNabb. G. (2002). Molecular epidemiology of human metapneumovirus in Canada. Health Canada Research Forum: From Science to Policy. Ottawa.Li. Y, Krishnan, J, Bastien, N, Jones, S, Feldmann, H, and Plummer, F. (2003). Expression and characterization of nucleocapsid (N) protein of SARS-associated Coronavirus: A candidate for early serologic diagnosis? International Science Symposium on SARS, Beijing, China. Li, Y., Normand, S., Bowness, D., and Bastien, N. (2003). Molecular epidemoiology of influenza B/Victoria/2/87 lineage viruses during the 2001-2002 influenza season in Canada. 5th International Conference “ Options for the Control of influenza V”. Okinawa, Japan.Li. Y., Tam. T., Bastien. N., Normand. S., Bowness. D., Klimov. A., and Cox. N. (2002). Re-emergence and spread of the influenza B /Victoria/2/87 lineage viruses during the 2001-2002 influenza season in Canada. Health Canada Research Forum: From Science to Policy. Ottawa. Li, Y., Thompson, V., Normand, S., and Bastien, N. (2002). Rapid screening and detection of amantadine-resistant influenza A viruses by single strand conformation polymorphism assay. XIIth International Congress of Virology, Paris, France. Lindsay LR, Drebot MA, Dibernardo A, Artsob H, Galloway T. 2001. Detection and phylogenetic characterization of granulocytic ehrlichiae from Ixodes scapularis ticks collected in Canada. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Lindsay LR, Drebot MA, Dibernardo A, Artsob H, Galloway T. 2001. Detection and genetic characterization of granulocytic ehrlichia from Ixodes scapularis ticks collected in various provinces of Canada. Annual Meeting of the American Society of Tropical Medicine and Hygiene, November 11-15, Atlanta, Georgia.Lindsay R, Dibernardo A, Drebot M, Ogden J, Baikie M, Horney B, Maloney R, Goltz J, Whitney H, Bennett K, Colbo M, McColl D, Artsob H. 2003. Studies of ticks and their associated pathogens in Atlantic Canada. International Conference on Diseases in Nature Communicable to Man, August 2-6, Flagstaff, Arizona.Lindsay R, Drebot M, Artsob H. 2003. West Nile virus surveillance strategies in North America and countries at risk, PAHO National Conference on West Nile virus, January 21, Kingston, Jamaica..Lindsay R, Drebot M, Dibernardo A, Artsob H, Gadawski, Weingartl, Copps J.2002. Assessment of the competence of field-collected Culex tarsalis mosquitoes to transmit West Nile virus under laboratory conditions. International Conference on Emerging Infectious Diseases 2002, March 24-27, Atlanta, Georgia.Lindsay R, Drebot M, Galloway T, Dibernardo A, Artsob H, Trudel L, Barker I. 2002. Surveillance for blacklegged ticks, Ixodes scapularis, and its associated pathogens in various provinces in Canada. IX International Conference on Lyme Borreliosis and other Tick-Borne Diseases, August 18-22, New York, New York.Lindsay R, Drebot, M, Dibernardo A, Trudel L, Barker I, Galloway T, Artsob H. 2002. Surveillance for blacklegged ticks, Ixodes scapularis, and associated pathogens (Borrelia burgdorferi, Ehrlichia phagocytophilia) in selected Canadian provinces. 57th International Conference on Diseases in Nature Communicable to Man, August 10-13, Vancouver,
Lindsay RL, Anderson R, Drebot M, Barker I, Nayar G, Dibernardo A, Artsob H. 2003. Evaluation of rapid diagnostic tests to detect WVN in corvids and mosquitoes, Annual Meeting of the Entomological Society of Manitoba, October 28-29, Winnipeg, Manitoba.Lindsay RL, Drebot M, Dibernardo A, Artsob H, Galloway T. 2001. Detection and genetic characterization of granulocytic ehrlichae from Ixodes scapularis ticks collected in Canada. Canadian Association for Clinical Microbiology and Infectious Diseases, November 4-8, Victoria, British Columbia.Liu C., C.Clark, E. Becker, T. Kruk and Gehua Wang*. 2002. A study on hlyA in A. hydrophila: a correlation between hemolytic activity levels and cytotoxicity titres. CACMIDLow DE, Hoban DJ, Bouchillon SK, Johnson JL, Min SB, Butler DL, Saunders KA, Poupard JA. A recent evaluation of in vitro activity of gemifloxacin (GEM), moxifloxacin (MOX), gatifloxacin (GAT) & levofloxacin (LEV) against 2,153 Streptococcus pneumoniae (SP) isolates recovered from sterile body sites: The FACTS Study, 2000-2001. American Society for Microbiology, Salt Lake City, Utah, May 2002.Low DL, Hoban DJ, Bouchillon SK, Johnson BM, Min SB, Butler DL, Saunders KA, Poupard JA. Determination of gemifloxacin (GEM), mosifloxacin (MOX), gatifloxacin (GAT) & levofloxacin (LEV) resistant Streptococcus pneumoniae (SP) isolates from respiratory and blood sources in a multi-center in vitro evaluation: The FACTS Study, 2000-2001. American Society for Microbiology, Salt Lake City, Utah, May 2002.Luo M, Embree J, Ramdahin S, Ndinya-Achola JO, Njenga S, Bwayo JJ, Jacobson K, Kwan L, Schroeder M, Pan S, Narayansingh MJ, Iqbal S, Mao X, Cheang M, Brunham R, Plummer F. HLA class I and class II alleles in Kenya, Africa: Disparity in diversity and evolutionary implications. Eleventh Annual Canadian Conference on HIV/AIDS Research (CAHR), Winnipeg, Canada; April 25-28, 2002. (Abstract # 144P)Luo M, Kimani J, Fowke K, Ball B, MacDonald K, Ramdahin S, Ndinya-Achola J, Njenga S, Bwayo JB, Maranan L, Bielawny T, Tuff J, Thavaneswaran S, Narayansingh MJ, Rutherford J, Slaney L, Embree J, Plummer F. Evolutionary implications of current HIV epidemic on the population of Kenya, East Africa: Study of population genetics by high resolution sequence-based HLA class I and class II typing 13th Canadian Conference on HIV/AIDS Research, Montreal, Canada; May 13-16, 2004. (Abstract # 126).Luo M, Kimani J, Fowke KR, Ball B, MacDonald K, Ndinya-Achola J, Njenga S, Bwayo JB, Ramdahin S, Maranan L, Bielawny T, Tuff J, Thavaneswaran S, Narayansingh MJ, Rutherford J, Slanley L, Embree J, Plummer FA. Resistance to HIV Infection- Heterozygotes Advantage and Evolution of HLA Molecular Mechanisms of HIV Pathogenesis Keystone Symposia, April 12-18, 2004 Whistler, B.C.Luo M, Kimani J, Fowke KR, Ball B, MacDonald K, Ramdahin S, Ndinya-Achola J, Njenga S, Bwayo JB, , Maranan L, Bielawny T, Tuff J, Thavaneswaran S, Narayansingh MJ, Rutherford J, Slanley L, Embree J, Plummer FA. Evolutionary Implications of Current HIV Epidemic on the Population of Kenya, East Africa: study of population genetics by high resolution sequence-based HLA Class I and Class II typing. Canadian Association for HIV Research, June 2004, Montreal, Canada.Luo M, Kimani J, Fowke KR, Ball TB, MacDonald KM, Ramdahin S, Ndinya-Achola J, Njenga S, Bwayo JB, Thavaneswaran S, Narayansingh MJ, Iqbal S, Embree J and Plummer FA. Evolutionary Implications of Current HIV Epidemic on the Population of Kenya, East Africa : study of population genetics by high resolution sequence-based HLA Class I and Class II typing. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada.
Macaulay A, Orr P, Macdonald S et al. Mortality in the Kivalliq region of Nunavut, 1987-1996. 12th International Congress of Circumpolar Health, Nuuk, Greenland, September 2003, Abstract 23.MacFarlane, N., Klass, L., Kennedy, J., Holota, K., Degagne, P., Hoban, S., Nicolle, L., Harding, G. Investigation of clindamycin-resistant C. difficile disease at an acute care hospital CHICA-Canada National Meeting, St. John’s, Newfoundland, June 4, 2002.Mackinnon J, Rahn K, Taboada E, Nash J, Taylor D, Gannon V, Graham T, Clark C, Farber J. Genomic approaches and in-vitro models for the investigation of virulence in Campylobacter. CACMID Nov, 2004 (Regina).Madariaga MG, Evans AT, Brobbey W, Phillips M, Lo E, Rezai K, Schwartz DN, Weinstein RA, Trenholme GM. Learning by Doing: Developing fellows’ academic skills through collaborative research. Abstract IDSA. 2002. poster presentation, manuscript submitted to Medical Education.Makokha J, Bwayo J, Ndiritu A, Gelmon L; A Regional Community Care Situation Analysis; presented at the XIIth International Conference on AIDS/STDs in Africa, Ouagadougou, Burkina Faso, December 2001; Abstract 12PT6-538, Abstract volume pg. 306
Mao X, Luo M, Rutherford J, Ramdahin S, Stuart T, Fowke K, Embree J, Plummer F. Development of a sequence-based typing method to type HIV viral RNA from serum samples. Eleventh Annual Canadian Conference on HIV/AIDS Research (CAHR), Winnipeg, Canada; April 25-28, 2002. (Abstract # 150P)Maureen H, Elliott A, Wylie J, Jolly A, Ormond M and Dawood M (2002) The Winnipeg social network injection drug use study: Focus group results. The 11th Annual Canadian Conference on HIV/AIDS Research.Mbugua F, F Okoth, M Gray, T Kamau, A Kalu, R Eggers, P Borus, J Kombich, A Langat, P Maritim, J Lesiamon and GA Tipples. Molecular epidemiology of measles virus in Kenya. 24th African Health Sciences Congress, Addis Ababa, Ethiopia, September 28 to October 2, 2003.McColl D, Kosoy M, Phelan L, Gage K, Artsob H. 2002. Bartonella testing at the National Microbiology Laboratory, Health Canada, 1993-2002. 57th International Conference on Diseases in Nature Communicable to Man, August 10-13, Vancouver, British Columbia.McCracken M, M.R. Mulvey, S. Giercke. P. Van Caeseele, J. Wylie. Molecular Characterization of Extended-Spectrum Beta-Lactamase Producing Escherichia coli in a Long Term Care Facility in Canada. Canadian Assocation for Clinical Microbiology and Infectious Diseases 72nd Conjoint Meeting on Infectious Diseases (CACMID), November 7-10, 2004, Regina, Saskatchewan.McKeown I, Reid S, Orr P. Childhood experiences of sexual violence and dislocation as social risk factors for HIV acquisition among Canadian women. 12th International Congress on Circumpolar Health, Nuuk, Greenland, September 2003, Abstract 141.
McKeown I, Reid S, Turner S, Orr P. Sexual Violence and Dislocation as Social Risk Factors involved in the Acquisition of HIV among Women in Manitoba. Ninth International Women and Health Conference, Toronto, August 2002.
McKinnon LR, Ball TB, Patenaude A, Rosser S, Fowke KR and Plummer FA. Prevalence of CD8+ T cell responses to African clades of HIV-1 env amongst HIV+ individuals from
Winnipeg, MB. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada. McLaren PJ , Mayne M, Matu L, Kimani J, Danesh A, Kelvin DJ, Plummer FA and Fowke KR. Immune Profiling of HIV-1 Resistant Commercial Sex Workers. Canadian Student Health Research Forum June 7-9 2004 Winnipeg, Canada. Received Manitoba Medical Services Foundation award for excellence.
McLaren PJ, Mayne M, Matu L, Kiama P, Kimani J, Plummer FA and Fowke KR. Gene Expression Analysis of p24-specific CD4+ T-cell Responses in HIV Resistant Commercial Sex Workers. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada. McLaren PJ, Mayne M, Plummer FA and Fowke KR. Kinetics of HIV-1 Specific Immune Gene Expression in CD4+ Cells in an HIV Infected Individual. Canadian Association for HIV Research Annual Meeting April 25-28 2002, Winnipeg, Canada.Meadows, E., Wylie, J. L., Jolly, A. M. Sexually transmitted disease networks of First Nations people in Manitoba. 2004. Health Canada Science Forum. Ottawa, CA. Meletiadis J, Choi EH, Walsh TJ, Pappas P, Ennis D, Douglas J, Panky G, Embil JM, Chanock S. A Pilot Study to Investigate Genetic Risk Factors Indicates that a Common Polymorphism is the Low Affinity Gama Fc Receptor FCGR2A, is Associated Infection with Cryptococcus neoformans but not Blastomyces dermatitidis. Submitted for 104th General Meeting of the American Society of Microbiology. New Orleans, May 23-27, 2004.Melito PL, Harvie S, Bryden L, Giercke S, Woodward DL, Van Caeseele P, Clark CG. A phenotypic and genotypic study of Helicobacter pylori antimicrobial susceptibility. In Abstracts of the Canadian Association for Clinical Microbiology and Infectious Diseases, 2002: 45.Mellmann A., S. Andrees, K. Blackwood, K. C. Carroll, D. Harmsen, A. Kabani, A. Roth and J. L. Cloud. Proposal for reporting criteria and evaluation of RIDOM, MicroSeq, and GenBank services for molecular differentiation of Nocardia species. 103rd General Meeting of the American Society for Microbiology, Washington DC. May 2003.Mendez, I.I., Y.-M. She, W. Ens, and K.M. Coombs. (2001). Evidence of reovirus core dynamics using limited proteolysis and mass spectrometry. American Society for Virology, University of Wisconsin-Madison, July 21-25.Mendez, I.I., Y.-M. She, W. Ens, and K.M. Coombs. (2002). Global conformation changes in mammalian reovirus: evidence of viral breathing. UA-UC Conference on Infectious Diseases. Banff, AB, April 23.Milley, D., B. Klisko and P. Van Caeseele. Comparison of Becton Dickinson’s Directigen Flu A+B kit with Viral Culture for the Detection of Influenza B. Presented at the 69th Conjoint Meeting on Infectious Diseases, Victoria, B.C. (CACMID, November 2001).Mink SN, Bose D, Cheng Z, Jacobs H, Light RB, Duke K. Lysozyme reduces the cardiac response to neural sympathetic stimulation in dogs. Am J Resp Crit Care Med 165:A172, 2002Mink SN, Cheng Z, Bose D, Jacobs H, Duke K, Light RB. Sepsis causes presynaptic histamine H3 and alpha 2 adrenergic dysfunction in canine myocardium. Am J Resp Crit Care Med 167:A550, 2003.
Mink SN, Jacobs H, Duke K, Bose D, Cheng Z, Light RB. N,N’,N’’- Triacetylglucosamine, an inhibitor of lysozyme, prevents myocardial depression in E.coli sepsis in dogs. Am J Resp Crit Care Med 169: A633, 2004.Morris C. First International Conference on Inner City Health, Toronto, Canada, October 2002, A model for te4aching inner city medicine to medical students in Vancouver, Canada.Morris C. First International Conference on Inner City Health, Toronto, Canada, October 2002, The use of photo-elicitation as a technique in working with IDU’s in inner city Vancouver, Canada.Morris C. XV International AIDS Conference, A description of sexual networking in Kenya using sex workers diaries.; Bangkok, Thailand.Morris C. XV International AIDS Conference, Economic neccessity and STD/HIV risk and vulnerability in sex workers in Nairobi, Kenya, Bangkok; Thailand.Morris C. XV International AIDS Conference, Empowering female sex workers as a strategy for HIV Control; Bangkok, Thailand.Morris C. XV International AIDS Conference, Enhancing community-based STI/HIV programming by sex workers in Nairobi, Kenya, Thailand.Morris C. XV International AIDS Conference, Gender mainstreaming in Kenya: a successful model for national policy development; Bangkok, Thailand.Morris C. XV International AIDS Conference, Harassment and violence against sex workers in Kenya ; Bangkok, Thailand.Morris C. XV International AIDS Conference, Mainstreaming gender into HIV/AIDS programming: a case study from Kenya; Bangkok, Thailand.Morris C. XV International AIDS Conference, Perceptions of female sex workers in Nairobi, Kenya to expanded economic activities; Bangkok, Thailand.Morris C. XV International AIDS Conference, Review of a workplace based program: the Kenya Ports Authority experience; Bangkok, Thailand.Morris C. XV International AIDS Conference, Sex is just sex? Sexual risk differentials among female sex workers in Kenya; Bangkok, Thailand.Morris C. XV International AIDS Conference, Sex work interventions for HIV/AIDS prevention and control: policy gaps-Kenya’s experience; Bangkok, Thailand.Moses S, Bailey RC, Agot K, Parker C, Ronald A, Ndinya-Achola JO. A randomized controlled trial of male circumcision to reduce HIV incidence in Kisumu, Kenya: preliminary results [Abstract 0329]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Moses S, Bailey RC, Agot K, Reda D, Maclean IW, Ronald AR, Ndinya-Achola JO. A randomized, controlled trial of male circumcision (MC) to prevent HIV infection in Kisumu, Kenya [Abstract D11315]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002Moses S, Bailey RC, Agot, K, Maclean I, Ronald AR, Ndinya-Achola JO. A randomized, controlled trial of male circumcision (MC) to prevent HIV infection in Kisumu, Kenya [Abstract 338P]. XI Annual Canadian Conference on HIV/AIDS Research, Winnipeg, Canada, April 25-28, 2002
Moses S, Bhattacharjee P, Washington R, Maddur S, Blanchard J. Evidence-based planning for HIV/AIDS control programming: experience from India [Abstract 0704]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Moses S, Kaul R, Kimani J, Ngugi EN, Fonck K, Nagelkerke NJD, Temmerman M. Monthly azithromycin chemoprophylaxis in Kenyan female sex workers reduces the incidence of STIs but not HIV: a randomized, placebo-controlled Trial [Abstract 0027]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Moses S, Kaul R, Kimani J, Ngugi EN, Fonck K, Nagelkerke NJD, Temmerman M. Monthly azithromycin chemoprophylaxis in Kenyan female sex workers reduces the incidence of STIs but not HIV: a randomized, placebo-controlled trial [Abstract 305221]. XIII International Conference on AIDS and STIs in Africa (ICASA), Nairobi, Kenya, September 21-26, 2003Moses S, Ngugi EN, Costigan A, Kariuki C, Plummer FA. Declining sexually transmitted disease and HIV prevalences among antenatal clinic (ANC) attenders in Nairobi, Kenya from 1992-2001 [Abstract WeOrC1272]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002Mubareka S, Alfa M. Booton G, Ekins E, Van Caeseele P. Acanthamoeba keratitis, in a soft contact lens wearer. Abstracts of the Canadian Infectious Diseases Society, 2003, in press.Mubareka S, Loeb M, Simor A, Liu B, McNeil S, Mazowita G, Nicolle L. Access to diagnostic tests for lower respiratory infection for residents of Canadian long term care facilities. Abstract 34. Can Jour Infect Dis 2004; 15: 117.Mubareka S, Orr P. Clinical Manifestations of West Nile Virus Infection: The Manitoba Experience. Resident Research Day, Department of Medicine, University of Manitoba, April 13, 2004.
Mubareka S. and K. Bernard Microbacterium spp Bacteremia Secondary to a Central Venous Catheter. CIDS/CAMM meeting March 7-9 2003 Québec City Québec.Muller M.P., Boyd, D., Ashi-Sulaiman A., Larocque C., Mulvey M., Reynolds D., McGeer A., Willey B.M. Molecular Characterization of an Outbreak Strain of Multidrug-Resistant (MDR) Escherichia coli Carrying UOE-1 with Dissemination of the Plasmid into Other Enterobacteriaceae. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Dec. 15-19, 2001.Muller M.P., Boyd, D., Ashi-Sulaiman A., Larocque C., Mulvey M., Reynolds D., McGeer A., Willey B.M. Characterization of and Epidemic Multidrug-Resistant (MDR) E.coli carrying a CTX-M-3 beta-lactamase. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, British Columbia, Nov. 4-7, 2001.Mulvey M. R., L. MacDougall, B. Cholin, D. Spreitzer, T. Du, R. McDonald, E. Nagle, G. Horsman, M. Fidyk, and S. Woods. Emergence of a Community-Associated MRSA Clone Harboring the Panton-Valentine Leukocidin Toxi in the Province of Saskatchewan, Canada. 11th Annual International Symposium on Staphylococci & Staphylococcal Infections, Charleston, SC. (C-15).Mulvey MR, J. L. Campbell, C. Watt, A. E. Simor, L. Bryden, S. Paton and the Canadian Nosocomial Infection Surveillance Program. Emergence of Three New Epidemic Strains of MRSA in Canada. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Regina, Saskatchewan, Nov. 7-10th, 2004.
Mulvey MR, Johnston L, Ofner M, Conly J, Du T, Hizon R, Embil J, Matlow A, Paton S, Simor A. Three Years of National Surveillance for Vancomycin-Resistant Enterococci (VRE) in Canada: 1998-2001. Abract C2-2164. 43rd Annual Interscience Conference on Antimicrobial Agents in Chemotherapy, Chicago, Illinois, September 17, 2003.Mulvey, M.R., Boyd, D.A., Baker, L., Ng, L., Rodrigues, D., Reis, E.M.F., Asensi, M.D. Molecular characterization of a multidrug resistant Salmonella enterica agona from Brazil: four beta-lactamases (2 ESBLs) and an integron containing two novel cassettes. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.Mulvey, M.R., Bryce, E., Boyd, D, Ofner-Agostini, M., Simor, A., Paton, S. Molecular characterization of extended-spectrum beta-lactamase producing organisms in Canadian hospitals over a one year period. 42rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA, Sept. 14-17, 2002.Mulvey, M.R., Bryce, E., Boyd, D.A., Christianson, S., Ofner, M., Simor, A.E., Paton, S. Characterization of plasmids harbouring extended-spectrum beta-lactamase genes from Canadian hospitals. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.Mulvey, M.R., Bryce, E., Boyd, D.A., Land, A.M. Ofner, M., Simor, A.E, Paton, S. Molecular characterization of cefoxitin resistant Escherichia coli from Canadian hospitals. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.Mulvey, M.R., Bryce, E., Hizon, R., Ofner-Agostini, M., Simor, A.E., Paton, S. Molecular Characterization of Extended-Spectrum Beta-Lactamase Producing Organisms in Canadian Hospitals. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, British Columbia, Nov. 4-7, 2001.Mulvey, M.R., L. Baker, D. Boyd, D. Rodrigues, E.M. Freis, M.D. Asensi, L.-K. Ng. 2002.Characterization of an integron containing novel OXA-type beta-lactamase and 6’-N-aminoglycoside acetyltransferase genes in a multidrug resistant Salmonella enterica serovar Agona harbouring three extended-sprectum beta-lactamases. ICAAC 2002.Mulvey, M.R., Tyler, S., Boyd, D.A., Wiley, B.M., Muller, M., McGeer, A. Complete nucleotide sequence of a 93 kb plasmid harbouring CTX-M-15 involved in a long-term care outbreak in Toronto. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.Mulvey, M.R., Tyler, S., Cote, T., Weiss, K. Identification of the first Enterococcus faecalis harbouring a vanG in Canada. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.Munro CK, K. Bernard, S. Tyler. Detection of Tropheryma whipplei from clinical materials using real time PCR. 71st CACMID meeting, Montreal, Que. Nov. 3 2003Munro JL, Clark CG, Rodgers FG, PulseNet North Participants. PulseNet North: Canada=s molecular subtyping network for enteric bacteria. CACMID, November 2001, Victoria, B.C.Murray M, Plummer F, Embree J. HIV-1 sequence variation and epidemiological factors in mothers with significantly reduced mother-child transmission rates. 13th Canadian Conference on HIV/AIDS Research, Montreal, Canada; May 13-16, 2004. (Abstract # 127).Ndiritu A, Bwayo J, Makokha J, Gelmon L; A Survey of HIV Interventions in the Workplace in Kenya; presented at the XIIth International Conference on AIDS/STDs in Africa, Ouagadougou, Burkina Faso, December 2001; Abstract 13PT7-680, Abstract volume pg. 433
Ng, L.-K., and A. Lau. 2003. Molecular typing Neisseria gonorrhoeae using clinical specimen for PCR diagnosis. 15th Biennial International Society for Sexually Transmitted Diseases Research (ISSTDR) Congress, Ottawa, July 29, 2003.Ng, L.-K., and J. Munro. 2004. The Evolution of PulseNet Canada: The national molecular subtyping network. ICEID meeting, Georgia, Atlanta, February 28-March 5, 2004.Ng, L.-K., and M. Mulvey. 2004. Molecular Characterization of a Cluster of Multidrug Resistant Salmonella Agonas from Brazil: Two ESBLS and an Integron Containing Two Novel Genes. ICEID meeting, Georgia, Atlanta, February 28-March 5, 2004.Ng, L.-K., I. Martin, and A. Lau. 2001. Plasmid mediated antibiotic resistance in Canadian Neisseria gonorrhoeae strains. The 2001 Conjoint Meeting of CACMID, CHICA and CIDS, Victoria, BC, November 4-8,2001.Ng, L.-K., I. Martin, and S. Booth. 2001. Detection of gyrA and parC mutations in N. gonorrhoeae using DNA array technology. The 2001 Conjoint Meeting of CACMID, CHICA and CIDS, Victoria, BC, November 4-8, 2001.Ng, L.-K., I. Martin, P. Sawatzky, L. Bryden, and A. Lau. 2001. Ciprofloxacin and macrolide resistant gonococci in Canada. The 2001 Conjoint Meeting of CACMID, CHICA and CIDS, Victoria, BC, November 4-8, 2001.Nichol K, Karlowsky JA, Zhanel GG and Hoban DJ. Genetic characterization of penicillin resistant Streptococcus pneumoniae. American Society for Microbiology, Orlando, Florida, 2001.Nichol K, Sill M, Laing N, Smith H, Johnson J, Hoban DJ and Zhanel GG. Distribution of vanA and vanB genotypes and molecular typing of vancomycin-resistant Enterococcus faecium (VREF) isolated in North America. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Nichol K, Smith H, Hoban DJ, Zhanel GG. Distribution of vanA and vanB genotypes and molecular typing of vancomycin-resistant Enterococcus faecium (VREF) isolated in North America. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 2002.Nichol K, Smith HJ, Hoban DJ and Zhanel GG. Genetic relationship of fluoroquinolone (FQ)-resistant Streptococcus pneumoniae (SP) in Canada. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Nichol KA, Sill M, Laing NM, Smith HJ, Hoban DJ, Zhanel GG. Molecular epidemiology of vancomycin-resistant Enterococcus faecium (VREF) in the United States (US): Results from 23 medical centres. American Society for Microbiology, Salt Lake City, Utah, May 2002.Nichol KA, Swedlow D, Wierzbowski AK, Palatnick LP, Smith HJ, Mulvey M, Hoban DJ, Zhanel GG. Identification of macrolide resistance mechanisms and distribution of efflux gene variants in Canadian isolates of Streptococcus pneumoniae: results of a five-year (1997-2002) national surveillance study. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Glasgow, UK, May 2003.Nichol KA, Zhanel GG, Hoban DJ. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae (SP) in Canada. Conjoint Meeting of CACMID, CHICA & CIDS, Victoria, BC, November 2001.Nichol KA, Zhanel GG, Hoban DJ. Molecular epidemiology of Penicillin-, Erythromycin- and Ciprofloxacin-resistant Streptococcus pneumoniae in Canada. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.
Nicolle, L.E. Geriatrics: Potential for abuse. Jour Antimicrob Chemother (Abstract 6.4) 2001; 47 (Suppl 1):9.Njenga S, Ndinya-Achola J, Bwayo JJ, Nduati R, Embree JE, Plummer FA. Factors associated with < 3 years survival of children born with HIV infection in Nairobi, Kenya. Fourteenth International AIDS Conference, Barcelona, Spain July 7-12, 2002 (Abstract # TuPeC4711). Noreddin A, Hoban D, and Zhanel GG. Monte Carlo analysis of gatifloxacin 400mg daily in hospitalized patients with community acquired pneumonia. International Congress of Chemotherapy (ICC), Durban, South Africa 2003. Noreddin A, Laing N, Hoban DJ and Zhanel GG. Monte Carlo simulation of bactericidal activity versus urinary tract infection E.coli of ciprofloxacin 500mg BID, gatifloxacin 200mg and 400mg OD and levofloxacin 500mg, 750mg and 1000 administered once daily. American College of Clinical Pharmacy (ACCP), Dallas, Texas, 2004.Noreddin A, Laing N, Nichol K, Wierzbowski A, Hoban D and Zhanel GG. In vitro pharmacodynamic modeling of the novel ketolide telithromycin versus PCR-positive mefA and ermB macrolide resistant strains of Streptococcus pneumoniae using an in vitro model. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Noreddin A, Laing N, Nichol K, Wierzbowski A, Hoban D, Zhanel GG. In vitro pharmacodynamic modelling of the novel ketolide telithromycin versus PCR-positive mefA and ermB macrolide resistant strains of Streptococcus pneumoniae using an in vitro model. Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 2001.Noreddin A, Laing N, Nichol K, Wierzbowski A, Hoban DJ and Zhanel GG. Pharmacodynamic simulation of ABT-773 a new ketolide against PCR positive mefA and ermB macrolide resistant strains of S.pneumoniae using an in-vitro model. International Congress of Chemotherapy (ICC), Amsterdam, 2001.Noreddin A, Marras T, Chan C, Hoban D, and Zhanel GG. Pharmacodynamic target attainment against Streptococcus pneumoniae using levofloxacin 500mg and 750mg once daily in hospitalized patients with community acquired pneumonia. International Congress of Chemotherapy (ICC), Durban, South Africa 2003. Noreddin A, Marras T, Chan C, Hoban D, and Zhanel GG. Target attainment analysis for gatifloxacin 400mg daily in immunocompromised patients hospitalized with community acquired pneumonia. America Society for Microbiology (ASM), Washington, District of Columbia 2003. Noreddin A, Marras T, Chan CK, Kuti J, Nightingale C, Hoban DJ and Zhanel GG. Pharmacokinetic simulation of levofloxacin in 557 elderly hospitalized patients with community acquired pneumonia. International Congress and Infectious Diseases (ICID), Singapore, March 11-14, 2002.Noreddin AM, Marras T, Chan C, Kuti J, Nightingale C, Hoban DJ and Zhanel GG, Pharmacokinetic simulation of levofloxacin in 263 elderly immunocompetent and 74 immunocompromised hospitalized patients. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Halifax, Nova Scotia, November 2002.Noreddin AM, Marras T, Chan C, Rodvold K, Hoban DJ and Zhanel GG. Pharmacodynamic target attainment analysis of levofloxacin 500mg, 750mg and 1000mg once daily in plasma and epithelial lining fluid of hospitalized patients with community acquired pneumonia.
Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Montreal, Quebec, November 2003.Noreddin AM, Smith H, Schurek KN, Greisman J, Nichol K, Hoban DJ and Zhanel GG. Fluoroquinolone pharmacodynamic indices based on genetically derived breakpoints for S.pneumoniae. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Montreal, Quebec, November 2003.Noreddin AM, Smith HJ, Nichol KA, Walkty A, Hoban DJ, Zhanel GG. Molecular characterization of clinical and laboratory fluoroquinolone-resistant Streptococcus pneumoniae. American Society for Microbiology (ASM), Washington, DC, May 2003.Noreddin AM, Smith HJ, Schurek KN, Siemens C, Nichol KA, Hoban DJ and Zhanel GG. Novel Pharmacodynamic target attainment indices for fluoroquinolone based on genetically driven breakpoints for S.pneumoniae. International Congress on Infectious Diseases (ICID), Cancun, Mexico, March 2004. Odek WO, Costigan A, Ngugi EN, Moses S, Plummer FA, Oneko M. Business success and failures among female sex workers: results from a Kenyan pilot project [Abstract MoPeF4129]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002Odek, WO, Costigan A, Ngugi EN, Moses S, Plummer FA, Oneko M. Adapting micro-finance to HIV vulnerable communities: lessons for scaling up from a Kenya pilot project targeting female sex workers [Abstract MoOrF1046]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002Olson A. B., M. Silverman, D. A. Boyd, A. McGeer, B. M. Willey, V. Pong-Porter, N. Daneman, and M. R. Mulvey. Identification of a progenitor of the CTX-M-9 group of extended-spectrum B-Lactamases from Kluyvera spp. 'Guyana'. Canadian Association for Clinical Microbiology and Infectious Diseases 72nd Conjoint Meeting on Infectious Diseases (CACMID), November 7-10, 2004. Olson, A. B., M. Silverman, D. A. Boyd, A. McGeer, B. M. Willey, V. Pong-Porter, N. Daneman, and M. R. Mulvey. 2004. Identification of a potential progenitor of the CTX-M-9 group of extended-spectrum B-lactamases from Kluyvera spp. isolated in Guyana. International Antiboitic Resistance Symposium (IARS). University of Manitoba. June 8th 2004.Pagotto F, Clark C, Farber J, Woodward D, and the Canadian Public Health Laboratory Network. Human infections in Canada caused by Listeria monocytogenes. XV International Symposium on Problems of Listeriosis (ISOPOL). Uppsala, Sweden, Sept. 12 – 15, 2004.Palatnick L, Weshnoweski B, Bellyou T, Karlowsky K, Rimmer E, Yashisht R, DeCorby M, Zhanel GG and Hoban DJ. Incidence of penicillin doxycycline macrolide and fluoroquinolone resistance in Streptococcus pneumoniae (SPN) in Canada: Results of the Canadian Respiratory Organism Susceptibility Study (CROSS), 1997-2003. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Montreal, Quebec, November 2003.Palatnick L, Weshnoweski B, Bellyou T, Topnik D, Zhanel GG, Hoban DJ. Evaluation of antibiotic susceptibility in 17,585 respiratory tract infection (RTI) pathogens collected across Canada from 1997-2003: Results of the Canadian Respiratory Organism Susceptibility Study (CROSS). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Parkyn G and G Tipples. Development of a Recombinant Antigen Based ELISA for the Detection of HHV-6-specific antibodies. Canadian Association for Clinical Microbiology and Infectious Diseases, Halifax, NS, November 3-6, 2002.
Parry H, Makokha J, Lee T, Gelmon LJ; Scaling Up Training for HIV/AIDS Community Initiatives in Eastern and Southern Africa; presented at the XIVth International AIDS Conference, Barcelona, Spain, July 2002; Abstract MoPeG4305, Abstract Vol 1, pg 334
Pasick, J., Weingartl, H., Clavijo, A., Riva, J., Kehler, H., Handel, K., Watkins, E., and Hills, K. Characterization of Avian Influenza Virus Isolates Submitted to the National Centre for Foreign Animal Disease Between 1997 and 2001. Presented at the 5th International Symposium on Avian Influenza, April 14 - 17, 2002, Athens, GeorgiaPelude, L., Wylie, J. L., Jolly, A. M. Social networks and infectious disease in First Nation injection drug users in Winnipeg. 2004. Health Canada Science Forum, Ottawa, CA. Peret, T.C., Boivin, G., Li, Y., Couillard, M., Humphrey, C., Osterhaus, A.D., Edman, D.D., and Anderson, L.J. (2002). Characterization of human metapneumovirus isolated in North America. International Conference on Emerging Infectious Disease 2002, Atlanta, Georgia.Petrelli D., Sharma, M. Kaushal, J. Wolfe, A. Al-Azem, E. Hershfield and A. Kabani. The Dominance of The Manitoba Type1 Strain: Strain-Related Virulence of a Mycobacterium tuberculosis Isolate. 103rd General Meeting of the American Society for Microbiology, Washington DC. May 2003.Phelan J, Haase D, Mahaffey S, Mann J, Morin M, Moses S, Patrick D, Shields S, Predy G, Rossi M, Sutherland D. Street youth and chlamydia: are the rates rising [Abstract 0565]? XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Phelan J, Shields S, Haase D, Mahaffey S, Moses S, Morin M, Patrick D, Predy G, Rossi M, Sutherland D. Street youth – sexual partnering and risk [Abstract 0572]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Phelan J, Shields S, Haase D, Mahaffey S, Moses S, Morin M, Predy G, Rossi M, Sutherland D, Patrick D. Street youth and hepatitis B [Abstract 0570]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Prasad E, Doyle J, Holloway K, Melan S, Artsob H, Drebot M. 2001. First Canadian report of an imported case of hantavirus cardiopulmonary syndrome (HCPS) from Argentina. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Prasad E, Drebot M, Holloway K, Artsob H. 2002. Dengue fever - report of an imported case and review. 57th International Conference on Diseases in Nature Communicable to Man, August 10-13, Vancouver, British Columbia.Prasad E, Willox D, McColl D, Artsob H. 2001. Rickettsiosis- Report of an imported case and review. International Northwest Conference on Diseases in Nature Communicable to Man, July 29- August 1, Winnipeg, Manitoba.Racine, T., and K.M. Coombs. (2004). Characterization of avian reovirus temperature-sensitive mutants. Prairie Universities Biological Symposium, Edmonton, Alberta, Feb. 19-21.Ramdahin S, Fowke K, Wayne S, Bullard J, Plummer F, Embree J. Design of novel sensitive and specific HIV nested primers for polymease chain reactoin of lymphocyte DNA. Eleventh Annual Canadian Conference on HIV/AIDS Research (CAHR), Winnipeg, Canada; April 25-28, 2002. (Abstract # 129P)
Safronetz D, Drebot M, Hjelle B, Xiao R, Artsob H, Lindsay R. (2004) Preliminary studies on the transmission dynamics of Sin Nombre virus in naturally-infected deer mice (Peromyscus maniculatus) collected in Manitoba, Canada.Safronetz D, M Petric, R Tellier, B Parvez and G Tipples. Human herpesvirus 6 and resistance to ganciclovir. Health Canada Research Forum, Ottawa, ON, November 18-19, 2002.Safronetz D, M Petric, R Tellier, B Parvez and G Tipples. Possible ganciclovir resistant human herpesvirus 6 in an infant. Canadian Association for Clinical Microbiology and Infectious Diseases, Halifax, NS, November 3-6, 2002.Sanders KM, Balter M, the TRACE study investigators (Zhanel GG). Poor guideline utilization in the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). American Thoracic Society 2003. Sandhu A, Gross M, Wylie J, Van Caeseele P, Plourde P. Pseudomonas aeruginosa necrotizing chondritis complicating helical ear piercing: Clinical and Public Health perspectives of a case report. Presented at American Academy of Pediatrics, 2003. Submitted to AJPH, 2003.Scheifele D, Law B, Halperin S for Members of the CPS/Health Canada IMPACT Network; Invasive pneumococcal infections in first nations children: IMPACT Hospitals, 1991-2001. Canadian National Immunization Conference, Victoria, B.C. Dec1-3, 2002. Poster AttSchisler T, Law B, Hutmacher M, Survey of the immunization - related knowledge, attitudes and beliefs of Manitoban mothers. Canadian National Immunization Conference, Dec 1-3, 2002; Victoria, BC. Poster AttSchisler T, Law B, Hutmacher M. Are pediatric nurses adequately prepared to act as vaccination advocates. Canadian National Immunization Conference, Dec 1-3, 2002; Victoria, BC Poster AttSchwartz U, Costigan A, Ngugi EN, Kimani J, Moses S, Price J, Plummer F. Characteristics of rural-based female sex workers of western province, Kenya –Abstract MoPeC3492]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002Schwartz U, Costigan A, Ngugi EN, Kimani J, Moses S, Price J, Plummer F. Sexual behaviour among female sex workers and male company workers in Western Province, Kenya [Abstract WePeC6169]. XIV International Conference on AIDS, Barcelona, Spain, July 7-12, 2002Severini A, Camus G., Boudreau S., Browne K.,. (2004) Two-Dimensional Western Blotting of HSV Type-Specific Antibody Response. 2004 Conjoint Meeting of CACMID, Regina, Nov 7-10.Severini A., Saggar J., Limmer B., N. Antonishy, N., and Horsman, G. (2003) Prevalence of Human Papillomavirus Mucosal Types in Saskatchewan. Abstract to the 2003 Conjoint Meeting of CACMID & AMQ. Montreal, Nov 2-5. Severini A., and Tipples G. (2001 )Structures of replicative intermediates of human herpesvirus 6. 2001 Cojoint meeting of CACMID, CHICA and CIDS - Victoria, Canada. November 4 - 8.Severini A., Garbutt M., and Tipples G. (2001) Structures of replicative intermediates of human herpesvirus 6. Fourth International Conference on Human Herpesviruses 6,7 and 8. Paris, France.
Severini, A., Hamkar, R., Mokhtari-Azad, T., Limmer, B, Mahmoodi, M., Seyedi Rashti, S.R., and Nategh, R.(2003) Prevalence and sequence analysis of human papillomavirus in cervical biopsy specimens from the Mazandaran province of Iran. Abstarct to the 5th International Multidisciplinary Congress Eurogin 2003, Paris, France, April 13-16.Shuttleworth L, K. Bernard, C. Munro et al. Creation and deployment of a mobile containment level (CL3) laboratory for on-site, counter bioterrorism activities. 70th CACMID meeting, Halifax, NS Nov. 4, 2002. Simor A. E., M. Ofner-Agostini, S. Paton, M. Mulvey, E. Bryce, M. Loeb, A. McGeer, and the Canadian Nosocomial Infection Surveillance Program. Clinical and Epidemiologic Features of Methicillin-Resistant Staphylococcus aureus (MRSA) in Elderly Adults. IDSA (Sept. 30-Oct. 3, 2004), Boston MA.Simor, A.E., Ofner-Agostini, M., Bryce, E., McGeer, A., Paton, S., Mulvey, M.R. Laboratory Characterization of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals: The Results of Five Years of National Surveillance 1995-1999. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Victoria, British Columbia, Nov. 4-7, 2001.Singer J, Carriere D, Martin B, Embil J. The Prevalence of Type 2 Diabetes in a Canadian Inuit Population. 12th Annual International Congress on Circumpolar Health, September 11, 2003, Nuuk, Greenland.Skowronski DM, Bungay V, Buxton J, Gilbert M, Gustafson R, Halperin B, Law B, Lovato C, Mawhinney T, McIntyre C, Naus M, Nicol A, Pielak K, Remple V. Marketing and Momentum: Using Models of Behaviour Change to Evaluate and Drive Immunization. Canadian National Immunization Conference, Dec 1-3, 2002; Victoria, BC. Poster, Att. Smieja, M., Mahony, J., Petric, M., Mazzulli, T., Fearon, M., Hawes, G., Dick, D., Booth, T., deKoning, L., Spafford, R., Haynes, L. and Richardson, S. (2004). Inter-Laboratory Comparison of SARS Serologic Testing. 20th Annual Clinical Virology Symposium and Annual Meeting of the Pan American Society for Clinical Virology, 25-28 April, Clearwater Beach, Flordia. Smith H, Nichol K, Walters M, Waltky A, Hoban DJ and G. G. Zhanel. In Vitro selection of fluoroquinolone resistance and determination of mutant prevention concentrations (MPC) in Streptococcus pneumoniae. International Congress of Chemotherapy (ICC), Amsterdam, 2001.Smith H, Nichol K, Hoban DJ and Zhanel GG. Impact of parC mutations and efflux on the mutant prevention concentrations (MPC’s) of fluoroquinolones (FQ’s) in Streptococcus pneumoniae (SPN). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Smith H, Nichol K, Palatnick L, Weshnoweski B, Bellyou T, Rimmer E, Hoban DJ and Zhanel GG. In-vitro activity of ABT-492 against ciprofloxacin-resistant Streptococcus pneumoniae. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Smith H, Nichol K, Palatnick L, Weshnoweski B, Zhanel GG and Hoban DJ. Stability of fluoroquinolone resistance in Canadian Streptococcus pneumoniae isolates. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Glasgow, Scotland 2003.Smith H, Nichol K, Palatnick L, Weshnoweski B, Zhanel GG and Hoban DJ. Molecular characterization of fluoroquinolone-resistant Streptococcus pneumoniae isolates from Canada. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Glasgow, Scotland 2003.
Smith H, Nichol K, Schurek H, Noreddin A, Hoban DJ and Zhanel GG. Designing fluoroquinolone breakpoints for Streptococcus pneumoniae based on genetic parameters. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2003.Smith H, Nichol K, Walkty A, Hoban DJ and Zhanel GG. Different contibution of efflux to fluoroquinolone (FQ) resistance in clinical isolates and laboratory created mutants of Streptococcus pneumoniae (SPN). European Congress of Clinical Microbiology and Infectious Diseases, Milan, Italy, April 24-27, 2002. Smith H, Nichol K, Walkty A, Zhanel GG and Hoban DJ. Molecular characterization of fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. International Congress and Infectious Diseases (ICID) , Singapore, March 11-14, 2002.Smith H, Nichol K, Walters M, Hoban DJ and Zhanel GG. Molecular characterization and mutant prevention concentration determination of single-step fluoroquinolone-resistant mutants of Streptococcus pneumoniae. International Congress and Infectious Diseases (ICID) , Singapore, March 11-14, 2002. Smith HG, Hoban DJ, Walters M, Nichol KA, Walkty A, Zhanel GG. Development and characterization of multi-step fluoroquinolone (FQ)-resistant mutants of Streptococcus pneumoniae. 10th International Congress on Infectious Diseases, Singapore, March 2002.Smith HJ, Nichol K, Hoban DJ, Zhanel GG. In vitro activity of ABT-492 against ciprofloxacin-resistant Streptococcus pneumonioae (CR SPN) compared to eight other drugs. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 2002.Smith HJ, Nichol KA, Walkty A, Hoban DJ, Zhanel GG. Different contribution of efflux to fluoroquinolone (FA) resistance in clinical isolates and laboratory-created mutants of Streptococcus pneumoniae (SPN). American Society for Microbiology, Salt Lake City, Utah, May 2002.Smith HJ, Nichol KA, Walkty A, Zhanel GG, Hoban DJ. Molecular characterization of fluoroquinolone (FQ)-resistant Canadian clinical isolates of Streptococcus pneumoniae (SPN). Conjoint Meeting of CACMID, CHICA & CIDS, Victoria, BC, November 2001.Smith HJ, Nichol KA, Walters M, Walkty A, Hoban DJ and Zhanel GG. In vitro selection of fluoroquinolone resistance and determination of mutant prevention concentration (MPC) in Streptococcus pneumoniae. American Society for Microbiology, Orlando, Florida, 2001.Smith HJ, Nichol KA, Walters M, Zhanel GG, Hoban DJ. Molecular characterization and mutant prevention concentration (MPC) determination of single-step fluoroquinolone (FQ)-resistant mutants of Streptococcus pneumoniae. Conjoint Meeting of CACMID, CHICA & CIDS, Victoria, BC, November 2001.Smith HJ, Nichol KA, Walters M, Zhanel GG, Hoban DJ. Molecular characterization and mutant prevention concentration (MPC) determination of single-step fluoroquinolone (FQ)-resistant mutants of Streptococcus pneumoniae. 10th International Congress on Infectious Diseases, Singapore, March 2002.Smith HJ, Schurek K, Nichol KA, Palatnick L, Weshnoweski B, Hoban DJ, Zhanel GG. Multi-year characterization of the resistance mechanisms and activity of ABT-492 against ciprofloxacin-resistant Streptococcus pneumoniae (CR SPN). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Smith HJ, Schurek K, Nichol KA, Palatnick L, Weshnoweski B, Zhanel GG, Hoban DJ. In vitro activity of Garenoxacin against 109 Ciprofloxacin-resistant Streptococcus pneumoniae (CR
SPN). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Smith HJ, Schurek KN, Nichol KA, Noreddin A, Hoban DJ, Zhanel GG. Designing fluoroquinolone (FQ) breakpoints (BP) for Streptococcus pneumoniae (SPN) based on genetic parameters. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Smith HS, Nichol K, Palatnick L, Weshnoweski B, Hoban DJ and Zhanel GG. Activity of BMS-284756 against molecularly characterized ciprofloxacin-resistant Streptococcus pneumoniae. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID) Halifax, Nova Scotia, November 2002.Stevens T, Hoban D, Bouchillon S, Johnson J, Gaylord C, Hackel M, McCarthy M, Person M, Johnson B. DRF 11057 a novel oxazolidinone, in vitro activity against five common species of anaerobes. European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Prague, Czech Republic, May 2004.Stirling BV, Ngugi EN, Costigan A, Kimani J, Nagelkerke NJD, Forget E, Plummer FA, Moses S. Cost-effectiveness analysis of three HIV prevention interventions in Kenya [Abstract 335549]. XIII International Conference on AIDS and STIs in Africa (ICASA), Nairobi, Kenya, September 21-26, 2003Stirling BV, Plummer F, Ngugi EN, Moses S, Kimani J, Costigan A, Forget E. Cost-effectiveness analysis of three HIV prevention interventions in Kenya [Abstract 0049]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Stuart, T.L., M. Luo, J. Kimani, E. Njagi, K.M.Coombs, and F.A. Plummer. (2001). Genetic variability of HIV-1 in commercial sex workers studied over time. American Society for Virology, University of Wisconsin-Madison, July 21-25.Stuart, T.L., M. Luo, J. Kimani, K.M. Coombs, and F.A. Plummer (2003). Highly exposed HIV-1 infected commercial sex workers assessed for HIV-1 superinfection. Canadian Association of HIV Research, Halifax, N.S., April 1-4.Suchak, A.A., Turenne, C., Kabani, A., Nicolle, L. Clinical disease caused by a novel Mycobacterium species. Canadian Infectious Diseases Society Meeting, Banff, March 1, 2002.Susky E., M.R. Mulvey, D.W. Morck, R.R. Read, Molecular Characterization of Cefoxitin Resistant Escherichia coli in Beef Cattle Entering Feedlots. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Regina, Saskatchewan, Nov. 7-10th, 2004.Susky E., M.R. Mulvey, D.W. Morck, R.R. Read, Molecular Characterization of Cefoxitin Resistant Escherichia coli in Beef Cattle from Four Southern Alberta Feedlots. International Antibiotic Resistance Symposium (IARS), Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, June 8, 2004.Susky E., M.R. Mulvey, D.W. Morck, R.R. Read, Prevalence and molecular characterization of cefoxitin resistant Escherichia coli in beef cattle entering feedlots. 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, D.C., Oct.30-Nov 2nd, 2004. Swanson, M.I., Y.-M. She, K. Cheng, E. Brown, W. Ens, and K.M. Coombs. (2002). High-resolution characterization of reovirus structural proteins by MALDI-Qq-TOF mass spectrometry. American Society for Virology, University of Kentucky-Lexington, July 20-24.
Swedlo D, Wierzbowski A, Nichol K, Boyd D, Hoban D, Mulvey M and Zhanel GG. Macrolide efflux is encoded by mefE and mefA genes in clinical isolates of S.pneumoniae in Canada. America Society for Microbiology (ASM), Washington, District of Columbia 2003. Talan DA, Klimberg IW, Nicolle, LE, Church DA, Kowolsky SF, Song J, Childs SJ. Once-daily extended release ciprofloxacin vs conventional twice-daily ciprofloxacin for the treatment of complicated urinary tract infections or acute uncomplicated pyelonephritis. Northeastern Section of the American Urological Association. 55th Annual Meeting, Sept 7, 2003. Halifax, Nova Scotia.Talan, D.A., Klimberg, I.W., Nicolle, L.E., Church, D.A., Kowalsky, S.F., Song, J., Childs, S.J. Once-daily extended release ciprofloxacin vs conventional twice-daily ciprofloxacin for the treatment of complicated urinary tract infections or acute uncomplicated pyelonephritis. American Urological Association Annual Meeting, April 26, 2003, Chicago.Thomas, Roger; Nicolle Lindsay; Sorensen, Thomas; Gregson, Daniel. Point-of-care testing in primary care. Alberta College of Family Physicians, 48th Annual Scientific Assembly. March 8th, 2003, Banff, Alberta.Tipples G, G Parkyn, M Gray, R Hamkar, T Mokhtari-Azad and S Ratnam. Laboratory aspects of the measles elimination program. Health Canada Research Forum, Ottawa, ON, November 18-19, 2002.Tipples G, J Hiebert, G Parkyn, G Peters, S Tyler and C Grose. Genomic approaches to studying varicella-zoster virus: implications for diagnostics and surveillance. Health Canada Research Forum, Ottawa, ON, November 18-19, 2002.Tipples G, R. Hamkar, T. Mokhtari-Azad, M. Gray, G. Parkyn, C. Head, and S. Ratnam. Assessment of IgM enzyme immunoassays for the diagnosis of measles. Canadian Association for Clinical Microbiology and Infectious Diseases, Halifax, NS, November 3-6, 2002.Tipples GA, G Peters, S Tyler, JS Hiebert, G Parkyn, C Grose. Sequencing of the first North American VZV genome. 27th International Herpesvirus Workshop, Cairns, Australia, July 2002.Tipples GA, D Safronetz and M Gray. Detection and Genotypic Analysis of Varicella-Zoster Virus by Real-time PCR. Canadian Association for Clinical Microbiology and Infectious Diseases, Montreal, Quebec, November 2-5, 2003.Tipples GA, D Safronetz, D Kumar, J Ball and A Humar. Diagnostics of Beta-herpesviruses in Solid Organ Transplant Patients. Canadian Association for Clinical Microbiology and Infectious Diseases, Montreal, Quebec, November 2-5, 2003.Tipples GA, J Hiebert, LE Maranan, D Cook and R Garceau. Varicella-zoster virus genotyping. Canadian Association for Clinical Microbiology and Infectious Diseases, Victoria, BC, November 4-8, 2001.Tipples GA, MA Drebot, N Bastien, Y Li, S Jones, H Feldmann, A Kabani, T. Booth, A. Andonov, M Fearon, F Jamieson, J Isaac-Renton, M Krajden, A McNabb, M Petric, F Plummer and the NML SARS investigation team. Analysis of SARS-associated coronavirus laboratory testing at the National Microbiology Laboratory (NML). Canadian Association for Clinical Microbiology and Infectious Diseases, Montreal, Quebec, November 2-5, 2003.Tipples GA, P Van Caeseele, V Loparev, M Dawood, W Mar, T Kruk, M Gray, B Wells, P Carriere, B Cistarelli and P McCusker. Lab Confirmed Reinfection of Varicella: a Case Study. Canadian Association for Clinical Microbiology and Infectious Diseases, Regina, Saskatchewan, November 7-10, 2004.
Tipples GA, R Hamkar, T Mohktari-Azad, M Gray, J Ball, C Head and S Ratnam. Performance of Rubella IgM Enzyme Immunoassays. Canadian Association for Clinical Microbiology and Infectious Diseases, Montreal, Quebec, November 2-5, 2003.Turenne, C. Y., D. Harmsen, E. Richter, J. Albert, A. Kabani, K. C. Carrol, and J. Cloud. Proposal for reporting criteria and evaluation of RIDOM, MicroSeq, and GenBank services for molecular differentiation of Mycobacterium species. 102nd General Meeting of the American Society for Microbiology. Salt Lake City, Utah. May 2002. (C-56)Turenne, C. Y., D. Harmsen, T. Pfeuffer, E. Richter, J. Albert, A. Kabani, K. C. Carrol, and J. L. Cloud. Comparison of the molecular identification of Mycobacteria by use of the RIDOM, MicroSeq, GenBank and RDP-II databases. European Congress of Clinical Microbiology and Infectious Diseases. Milan, Italy. April 2002.Turenne, C., L. Thibert, K. Williams, T. V. Burdz, V. J. Cook, J. Wolfe, A. Kabani. Mycobacterium saskatchewanense sp. nov., a new slow-growing scotochromogenic species related to Mycobacterium interjectum and Accuprobe positive for M. avium complex from human clinical isolates. 24th Annual Congress of the European Society of Mycobactreriology. Tartu, Estonia, June 2003.Turenne, C., V. Cook, R. J. Pauls, T. V. Burdz, L. Thibert, J. Wolfe, A. Kabani. 2003. Mycobacterium parascrofulaceum sp. nov., a novel slowly growing scotochromogenic clinical isolate. 24th Annual Congress of the European Society of Mycobactreriology. Tartu, Estonia, June 2003.Vouriot FCM, Wayne S, Bellas J, Embree JE, Plummer FA and Fowke KR. The Role of a CD4 Polymorphism in Mother to Child HIV Transmission. Canadian Association for HIV Research Annual Meeting April 10-14 2003, Halifax, Canada.Vouriot FCM, Wayne S, Bellas,J, Embree JE, Plummer FA and Fowke KR. The Effect of a CD4 Polymorphism on the Mother to Child Transmission of HIV. Canadian Student Health Research Forum May 13, June 2003, Winnipeg, Canada. Vouriot FCM, Wayne S, Luo M, Bellas J, Kimani J, Ball TB, Elliott, L., Simonsen JN, Plummer FA and Fowke KR. A CD4 polymorphism is associated with altered HIV-1 disease progression in Kenyan women. Canadian Student Health Research Forum May 2004, Winnipeg, Canada. Winner of Faculty of Medicine Manitoban Poster Prize
Waruk, J., Berry, J.D., Ball, T., and FA Plummer. 2003. Mass spectrometry epitope mapping of a potent HIV-1-neutralizing monoclonal antibody (IgG1b12) reveals a previously undescribed gp120 binding specificity. Oral presentation (by J.W.) At: 13th Canadian CAHR conference, Hamilton, April 10-13.Waruk, J., Berry, J.D., Fowke, K., and F. Plummer. (2002) Mapping neutralizing epitopes on HIV1 using time of flight mass spectrometry. Oral presentation (by J.W.) At: 12th Canadian CAHR conference, Winnipeg, April 26-28th.Washington RG, Ramesh BM, Moses S, Blanchard J, Gurnani V, Kumar D. A strategic approach to capacity building of STI care services in Karnataka, India [Abstract 0633]. XV Biennial Congress of the International Society for STD Research (ISSTDR), Ottawa, Canada, July 27-30, 2003Weingartl H, Berhane Y, Czub M, Ranadheera C, Sawatsky B, Grolla A, Czub S, Copps J, Marszal P, Smith G, Gren J. (2004) NCFAD diagnostic capability for emerging zoonotic diseases. Focus on the porcine respiratory and encephalitis syndrome. Presentation at the CAHLN 2004, Guelph, Canada, May 16 - 19.
Weingartl H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones, S, Proulx R, Deschambault Y, Dick D, He R, Li Y, Andonov A, Berry J, Cao J. (2004) Evaluation of safety and efficacy of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. Presentation at the “International Conference on SARS - one year after the (first) outbreak. Lubeck, Germany, May 8 - 11.Weingartl H. Development of Rapid Field Tests fro Agro-Bioterrorism Agents. Invited presentation at CRTI Summer Symposium, Gatineau, Canada, June 24 - 25, 2003Weingartl HM, Copps J, Drebot MA, Marszal P, Smith G, Gren J, Andonova M, Pasick J, Kitching P, Czub M. (2003)Susceptibility of Pigs and Chickens to SARS Coronavirus. Invited presentation. First International Conference on SARS, Kuala Lumpur, Malaysia, June 17 - 18.Weingartl HM, Middleton D, Copps J, Czub S, Neufeldt J, Marszal P, Smith G, Muscialli J, Gren J. (2003) Experimental infection of pigs with Nipah virus. Early virus distribution and shedding. Presentation at the 4th International Conference of Emerging Zoonoses, Ames, Iowa, USA, September 18 - 21. Wierzbowski A, Nichol K, Noreddin A, Palatnick L, Hoban DJ and Zhanel GG. Incidence of mefA and ermB-positive Streptococcus pneumoniae in Canada: Results of a 4 year (1997-2001) national surveillance study. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Wierzbowski A, Nichol K, Smith HJ, Zhanel GG, Hoban DJ. Macrolide efflux (mef) gene is not carried on Tn1207.1 in Canadian isolates of Streptococcus pneumoniae. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 2002.Wierzbowski AK, Nichol KA, Boyd D, Hoban DJ, Mulvey M, Zhanel GG. Expression of macrolide efflux is inducible in clinical isolates of Streptococcus pneumoniae isolated in Canada. Conjoint Meeting on Infectious Diseases (CACMID), Halifax, Nova Scotia, November 2002. Wierzbowski, A.K., Nichol, K., Boyd, D., Hoban, D.J., Mulvey, M., Zhanel, G.G. Macrolide Efflux genetic assembly (mega) insertions in clinical isolates of macrolide-resistant Streptococcus pneumoniae containing mefE in Canada. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.Wierzbowski, A.K., Nichol, K., Boyd, D., Hoban, D.J., Mulvey, M., Zhanel, G.G. Macrolide efflux (mef) gene is not carried on Tn1207.1 in Canadian isolates of Streptococcus pneumoniae. 42rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA, Sept. 14-17, 2002.Wierzbowski, A.K., Nichol, K., Boyd, D., Noreddin, A., Hoban, D.J., Mulvey, M., Zhanel, G.G. Expression of Efflux pump gene (mef) increases in Canadian clinical isolates of Streptococcus pneumoniae with decreased susceptibility to macrolides. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Il., Sept. 14-17, 2003.Wolfe J., V. J. Cook, C. Y. Turenne, R. Pauls, and A. M. Kabani. Conventional Methods versus 16S rDNA Sequencing in the Identification of Nontuberculous Mycobacteria: A Cost Analysis. Canadian Association for Clinical Microbiology and Infectious Diseases, Halifax, NS. November 2002.Wong T, Burton S, Cormier L, Embree J, Steben M, Rusen ID, Canadian Paediatric Surveillance program (CPSP). Neonatal herpes simplex virus (HSV) infection in Canada. International Society for Sexually Transmitted Disease Research (ISSTDR) International Congress. Ottawa, ON, Canada, July 27-30,2003.
Woodward DL, Caldeira R, Ahmed R, Soule G, Clark CG, Bryden L, Melito P, Tabor H, Foster R, Walsh J, Malcolm GB, Strockbine N. A new emerging Shigella serotype B Shigella boydii 20. CACMID, November 2002. Wu H.X., G. Smart, G.Zaniewski, Z. Hong, J. Wu, N.J. Goedhuis, A.Giulivi , M. Dawood (2004) Changes in the epidemiology of hepatitis A infection in Manitoba 1992-2003: implications for vaccination strategies. The 6th Canadian Immunization Conference - MontrealWylie J, Jolly A, Elliott A, Maureen H, Ormond M and Dawood M (2002). The Winnipeg social network injection drug use study: Project overview and analyses of gender and ethnic-based differences an individual and social network drug use behaviors. The 11th Annual Canadian Conference on HIV/AIDS Research.Wylie, J. L., A. Jolly, A. Elliott, M. Heaman, M. Ormond, and M. Dawood. 2001. The Winnipeg social network injection drug use study: project overview and analysis of gender- and ethnic-based differences in individual and social network drug use behaviours. 11th annual conference on HIV/AIDS research, Winnipeg, Manitoba. Wylie, J. L., A. M. Jolly, and T. Cabral. 2003. Linking molecular genotype data with sexual network data: the transmission dynamics of Chlamydia trachomatis in Manitoba, Canada. XXII International Sunbelt Social Network Conference. Cancun, Mexico. Wylie, J. L., and D. L. Nowicki. 2004. Community- and Healthcare-acquired Methicillin-resistant Staphylococcus aureus in Manitoba, Canada. CACMID, Regina, SK. Wylie, J. L., Cabral, T., and A. M. Jolly. 2004. Combining molecular, geographic, and social data to identify Chlamydia trachomatis transmission networks. CACMID, Regina, SK.Xiao Y, P-A. Bonicard, X-J Yao, and E.A Cohen. Direct association of HIV-1 Vpr and matrix (MA) proteins in viral particles: implication for early events of HIV-1 infection. CAHR 2004: Translation of Science into Health. 13th Annual Canadian Conference on HIV/AIDS Research. Montreal, Quebec. May 13-16, 2004.Yang J., S. Wang, Y. Fan, X. Yang. Early mycobacterial infection prevents airway eosinophilia but not IgE responses in a murine model of asthma-like reaction. 11th international congress of immunology, July 22-27, 2001, Stockholm, Sweden.Yao X-Y, N. Daniel, Zhujun Ao, Nicole Rougeau and E.A Cohen. Specific killing of HIV-1 infected cells and virus mediated by Vpr-caspase-8 fusion protein. CAHR 2001: Tenth Annual Canadian Conference on HIV/AIDS Research. Sheraton Central Hotel. Toronto, Ontario. May 31-June 3, 2001.Yao X-Y, N. Rougeau, D Ghislaine and E.A. Cohen. HIV-1 Vpr determinants responsible for cell growth arrest in saccharomyces cerevisiae are not critical for cell-cycle alteration and apoptosis in human cells. Retroviruses Meeting, Cold Spring Harbor. New York. May 25 - 31, 2004.Yoshida C, McQuiston J, Franklin K, Fitzgerald C, Rahn K, Taboada E, Fields P, Nash J, Clark C. Design and evaluation of a Salmonella typing microarray. CACMID Nov, 2004 (Regina).Yoshida C, McQuiston J, Rahn K, Taboada E, Franklin K, Clark C, Fields P, Nash J. Salmonella antigen detection using microarray analysis. Microarray Gene Expression Data (MGED) Workshop, Toronto, Sept 8 – 10, 2004.Zafošnik I, Pipenbaher N, Moeller PL, Weingartl H, Cencic A, Jakobsen M.(2004) Stimulation of proinflammatory response in intestinal epithelial cells and macrophages by probiotic bacteria. Presentation at “INRA-RRI, 2004: Gut microbiology. Concerns and reposnses to food safety, health and environmental issues. Clermont-Ferrand,France, June 21 - 23.
Zelenitsky S, Iacovides H, Ariano R, Harding G. Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multi-dose, in vitro infection model. Presented at the 42nd Annual ICAAC. San Diego, CA. September 27 – 30, 2002.Zelenitsky S, Sun S, Ariano R, Harding G. Optimal antibiotic pharmacodynamics in the treatment of Pseudomonas aeruginosa bacteremia. Presented at the 42nd Annual ICAAC. San Diego, CA. September 27 – 30, 2002.Zhanel GG, Aoki F, Palatnick L, Nichol K, Hoban DJ. Discordance in antibiotic resistance between bacteremic and respiratory isolates of Streptococcus pneumoniae: Results of a 3 year (1999-2002) Manitoba bacteremic/respiratory organism surveillance study. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 2002.Zhanel GG, Bewick B, Laing N, Noreddin A, Nichol K, Smith H, Hoban DJ. Pharmacodynamic activity of levofloxacin simulating free concentrations obtained in both healthy volunteers and patients with community acquired pneumonia vs. ParC mutants of Streptococcus pneumoniae using an in vitro model. 10th International Congress on Infectious Diseases, Singapore, March 2002. Zhanel GG, Chan CK, Gin As, Carrie A, Nichol K, Smith H, Hoban DJ. Relationship Between Fluoroquinolone Use and Fluoroquinolone Resistance in Streptococcus pneumoniae: Analysis of National Canadian Data from 1997-2002. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Zhanel GG, Decorby M, Noreddin A, Bewick B, Laing N, Nichol K, Forgie S and Hoban DJ. Pharmacodynamic modeling of beta-lactams versus penicillin-resistant Streptococcus pneumoniae simulating clinically achievable free serum concentrations. Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), Halifax, Nova Scotia, November 2002.Zhanel GG, Gin AS, Chan CK, Carrie A, Smith H, Nichol K, Hoban DJ. Relationship between fluoroquinolone use and fluoroquinolone resistance in Streptococcus pneumoniae: Analysis of national Canadian data from 1997-2003. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Zhanel GG, Goolia M, Selin C, Laing N, Noreddin A and Hoban DJ. Pharmacodynamic activity of fluoroquinolones (FQ’s) against Bacteroides fragilis: Results simulating clinically achievable free serum and free stool concentrations in an in vitro model. International Congress on Infectious Diseases (ICID), Cancun, Mexico, March 2004. Zhanel GG, Harris R, Noreddin A and Hoban DJ. Pharmacodynamic (PD) activity of free garenoxacin compared to ciprofloxacin levofloxacin and ofloxacin versus Streptococcus pneumoniae using an in vitro pharmacodynamic model (IVPM). American College of Clinical Pharmacy (ACCP) 2003.Zhanel GG, Harris R, Noreddin A, Nichol K, Smith H, Hoban DJ. Pharmacodynamic activity of free garenoxacin vs. ciprofloxacin-resistant Streptococcus pneumoniae (Cip-R SPN) using an in vitro model. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Zhanel GG, Hisanada TL, Decorby MR, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Johnson J, Harding GKM, the NAUTICA Group and Hoban DJ. Antibiotic Activity Against Ampicillin (A), Ciprofloxacin (C), Trimethoprim/Sulfamethoxazole (TS) and Multi-Drug Resistant (MDR) Outpatient Urinary Isolates (OUI) of Escherichia coli. Presented at the 2003 Conjoint Meeting of CACMID and AMQ. Montreal, Quebec. November 2 – 5, 2003.
Zhanel GG, Hisanaga T, DeCorby M, Laing N, Nichol K, Palatnick L, Johnson J, Harding GKM the NAUTICA group and Hoban D. Antibiotic resistance in outpatient urinary tract isolates: Results from the North America Urinary Tract Infection Collaborative Alliance (NAUTICA). America Society for Microbiology (ASM), Washington, District of Columbia 2003. Zhanel GG, Hisanaga T, DeCorby M, Laing N, Nichol K, Palatnick L, Johnson J, Harding GKM, the NAUTICA group and Hoban DJ. Antibiotic resistance in outpatient urinary isolates: Interim results from the North America Urinary Tract Infection Collaborative Alliance (NAUTICA), European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Glasgow, Scotland 2003.Zhanel GG, Hisanaga T, DeCorby M, Laing N, Nichol K, Palatnick L, Noreddin A, Johnson J, Harding GKM, the NAUTICA group and Hoban DJ. Antibiotic activity against ampicillin, ciprofloxacin, trimethoprim-sulfamethoxazole and multidrug resistant oupatient urinary isolates of Escherichia coli: Results from the North America Urinary Tract Infection Collaborative Alliance (NAUTICA). International Congress on Infectious Diseases (ICID), Cancun, Mexico, March 2004. Zhanel GG, Hisanaga TL, DeCorby MR, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Johnson J, Hoban DJ. Activity of Garenoxacin against outpatient urinary isolates from North America. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Zhanel GG, Hisanaga, T.L., DeCorby M.R., Laing N. M., Nichol K.A., Palatnick L.P., Johnson J., Harding GKM, The NAUTICA group, D. J. Hoban: Antibiotic Resistance in Outpatient Urinary Isolates: Results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Presented at the 103rd General Meeting of The ASM Chicago, IL. May 19, 2003.Zhanel GG, Laing N, DeCorby M, Palatnick L, Nichol KA, Hoban DJ. Fluoroquinolone activity against clinical isolates of Bacteroides fragilis: Susceptibility and kill curve studies. American Society for Microbiology, Salt Lake City, Utah, May 2002.Zhanel GG, Laing N, Noreddin A, Nichol K, Bellyou T, Palatnick LP, Johnson J the NAVRESS group and Hoban DJ. Antibiotic Activity Against Urinary Tract Infection (UTI) Isolates of Vancomycin-Resistant Enterococci (VRE): Results from the North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). Infectious Diseases Society of America, San Francisco, September 25-28, 2001.Zhanel GG, Laing N, Noreddin A, Nichol K, Palatnick LP, Johnson J the NAVRESS group and Hoban DJ. Prevalence of Urinary Infection Caused by Vancomycin-Resistant Enterococci (VRE): Results from the North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). Infectious Diseases Society of America, San Francisco, September 25-28, 2001.Zhanel GG, Laing NM, DeCorby M, Nichol KA, Hoban DJ. Pharmacodynamic (PD) activity of fluoroquinolones (FQ) in a mixed infection simulating an artificial bowel: Effect of eradicating Bacteroides fragilis. American Society for Microbiology, Salt Lake City, Utah, May 2002.Zhanel GG, Noreddin A, Bewick B, Laing N, Roberts D, Nichol K, Wierzbowski A, and Hoban DJ. In vitro Pharmacodynamic Modelling of Clarithromycin and Azithromycin Simulating Serum and Epithelial Lining Fluid (ELF) Concentrations Versus mefA and ermB Macrolide-Resistant Streptococcus pneumoniae. International Conference on Macrolides Azalides Streptogramins Ketolides and Oxazolidinones (ICMASKO), Bologna, Italy, January 23-25, 2002.
Zhanel GG, Noreddin A, Laing N, Nichol K, Wierzbowski A, and Hoban DJ. In Vitro Pharmacodynamic Modelling of ABT-773 Simulating Once and Twice Daily Dosing against PCR- Positive mefA and ermB Macrolide Resistant Streptococcus pneumoniae. International Conference on Macrolides Azalides Streptogramins Ketolides and Oxazolidinones (ICMASKO), Bologna, Italy, January 23-25, 2002. Zhanel GG, Noreddin A, Roberts D, Nichol K, Weirzbowski A, Bellyou T, Laing N and Hoban DJ. In vitro pharmacodynamic modelling of clarithromycin simulating serum (S) and epithelial lining fluid (ELF) concentrations versus mefA and ermB macrolide-resistant Streptococcus pneumoniae. International Congress of Chemotherapy (ICC), Amsterdam, 2001.Zhanel GG, Palatnick L, Hisanaga T, Nichol K, Hawser S, Islam K, and Hoban DJ. Activity of garenoxacin against outpatient urinary isolates from North America. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2003.Zhanel GG, Palatnick L, Hisanaga T, Noreddin A, Nichol K, and Hoban DJ. ABT-492 demonstrates potent activity against Canadian lower respiratory tract infection pathogens isolated from 2001-2003. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2003.Zhanel GG, Palatnick L, Nichol KA, Bellyou T, Low DE, The CROSS Study Group, Hoban DJ. Incidence of penicillin, doxycycline, macrolide and fluoroquinolone resistant Streptococcus pneumoniae (SPN) in Canada: results of the Canadian Respiratory Organism Susceptibility Study (CROSS), 1997-2002. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, California, September 2002. Zhanel GG, Palatnick L, Smith H, Nichol K, Hoban D. ABT-492 Demonstrates potent activity against Canadian lower respiratory tract infection (RTI) pathogens isolated in 2001-2002. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Zhanel GG, Palatnick L, Smith H, Noreddin A, Nichol K, Hoban DJ. ABT-492 Demonstrates potent activity against Canadian lower respiratory tract infection (RTI) pathogens isolated from 2001-2003. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Zhanel GG, Palatnick L, Weshnoweski B, Smith H, Nichol K and Hoban DJ. BMS 284756 demonstrates potent activity against Canadian lower respiratory tract infection (RTI) pathogens isolated in 1999-2001. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Zhanel GG, Palatnick LP, Hisanaga TL, Nichol KA, Hawser S, Islam K, Hoban DJ. Activity of Iclaprim against penicillin, erythromycin, trimethoprim/sulfamethoxazole or ciprofloxacin resistant Streptococcus pneumoniae from Canada. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2003.Zhanel GG, Roberts D, Laing N, Noreddin A, Nichol K, Hoban DJ. Pharmacodynamic activity simulating free serum concentrations of lactams, macrolides and fluoroquinolones against ß-lactamase negative and positive Haemophilus influenzae using an in vitro model. 10th International Congress on Infectious Diseases, Singapore, March 2002.Zhanel GG, Roberts D, Nichol K, Bellyou T, Laing N and Hoban DJ. Pharmacodynamics of respiratory fluoroquinolones vs. ciprofloxacin-resistant S.pneumoniae. International Fluoroquinolone Meeting, Edinburgh, Scotland, 2001.
Zhanel GG, Smith H, Walkty A, Nichol K and Hoban DJ. Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae. International Fluoroquinolone Meeting, Edinburgh, Scotland, 2001.Zhanel GG, Wierzbowski A, Nichol K, Noreddin A, and Hoban DJ. Activity of ABT-773 vs. Macrolide-Susceptible and Resistant S. pneumoniae, H.influenzae and M.catarrhalis: Results of a 3 Year (1999-2002) Canadian Respiratory Organism Surveillance Study (CROSS). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, California, September 2002.Zhanel GG, Wierzbowski A, Noreddin A, Nichol K and Hoban DJ. In vitro activity of ABT-773 vs. macrolide-susceptible and resistant S.pneumoniae H.influenzae and M.catarrhalis: Results of a 2 year (1999/2000 and 2000/2001) Canadian respiratory organism surveillance study (CROSS). Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, Illinois, September 2001.Zhang Y, Laing C, Graham TA, Said K, Pegg C, Baxi M, Thomas J, Steele M, Ziebell K, Johnson R, Bekal S, Clark C, Gannon PJ. Characterization of genomic diversity of Escherichia coli O157:H7 using an oligonucleotide microarray. Health Canada Science Forum, Ottawa, Oct. 2004.Zoutman DE. Canadian Hospital Epidemiology Committee (Mulvey M, Embil J, and Embree J, Members), Canadian Nosocomial Infection Surveillance Program. The influence of surveillance and control activities on MRSA, VRE, and CDAC rates in acute care hospitals: RICH outcome study. Annual Conference, Community and Hospital Infection Control Association - Canada, Thunder Bay, ON, June 23-26,2003.
